<<

136

1970/18

THE DRUG TARIFF 1970

PuRSUANT to the Social Security Act 1964, the Minister of Health hereby gives the following direction.

ANALYSIS 11. Official requirements not in the First 1. Title and commencement Schedule to the Prescription 2. Interpretation Pricing Schedules 12. Rounding calculations 13. Minimum charges PART I-GENERAL RULES AFFECTING 14. Water THE TARIFF 15. Bulk supply orders and medical 3. Scope of Tariff practitioners' supply orders 4. Rules for standard 16. Proprietary .preparations 5. Prices for pharmaceutical require­ 17. Rec tified spirit ments PART Ill-MISCELLANEOUS PROVISIONS 18. Claims on the Department PART II-RuLES FOR PRICING 19. Allergy treatment sets 6. Application of rules for pricing 20. Intravenous flu~ds 7. Prescription pricing 21. Payment for anaesthetic gases 8. Computation of selling price 22. Period and quantity of supply 9. Items not listed in the First 23. Bulk supply orders Schedule to the Prescription 24. Medical practitioners' supply orders Pricing Schedules 25. Revocations and savings 10. Items dispensed by count Schedules

THE DRUG TARIFF 1. Title and commencement-( 1) This direction may be cited as the Drug Tariff 1970. (2) llhis direction shall come into force on the 1st day of April 1970, and shall apply to all pharmaceutical requirements supplied on or after that date to persons entitled to claim pharmaceutical benefits under the Social Security Act 1964, and to the supply on or after that date of pharmaceutical requirements to such persons as aforesaid. 2. Interpretation-( 1) In this direction, unless the context otherwise requires,- "Commission" means the Trade Practices and Prices Commission constituted under the Trade Practices Act 1958 or the Price Tribunal constituted under the Control of Prices Act 1947 or any person to whom the powers of either are delegated: "Director-General" means the Director-General of Health within the meaning of section 5 of the Health Act 1956: 1970/18 Drug Tariff 1970 137

"Hospital Board" means a Hospital Board constituted under the Hospitals Act 1957: . .. . "Licensed hospital" means a licensed hospItal wrthm the mearung of Part V of the Hospitals Act 1957: "Material allowance" means the allowance specified in :the column headed "Material Allowance" in the Table of Allowances: "Narcotic" means any substance, preparation, or mixture for tihe time being named or described in the First Schedule to the Narcotics Act 1965: "Outpatient" means' any person being treated at any hospital under the control of a Hospital Board otherwise than as an inmate: "Payment" means payment by the Department in accordance with the terms of this Tariff: "Prescription Pricing Schedules" means the official schedules and amendments for prescription pricing issued by the Depart­ ment from time to time for the purpose of determining the prices to be paid to contractors in respect of pharmaceutical requirements supplied by them: "Proprietary preparation" means any pharmaceutical require­ ment that is prescribed in any prescription by reference to any trade mark or trade name or by reference to the name of its manufacturer: "Registered nurse" means a registered nurse within the meaning of the Nurses and Midwives Act 1945: "The regulations" means the Social Security (Pharmaceutical Benefits) Regulations 1965*: "Selling price" means the price specified in the column headed "Prescription Selling Price" in the First Schedule to the Prescription Pricing Schedules or as calculated under clause 9 or clause 10 of this Tariff, as the case may be: "Table of Allowances" means the Table of Allowances on Specified Proprietary Products in the Prescription Pricing Schedules: "Tariff" means the Drug Tariff 1970. (2) Except as provided in this clause, expressions defined in section 88 of the Social Security Act 1964 and in regulation 2 of the regulations have the meanings so defined.

PART I-GENERAL RULES AFFECTING THE TARIFF 3. Scope of Tariff-All , drugs, and materials specified in the Schedule to this Tariff, and all preparations of anyone of them having an inert base, shall, subject to the restrictions (if any) as to their availability specified in that Schedule, be deemed to be included in this Tariff and to be pharmaceutical requirements for its purposes: Provided that 'pr~parations which ha~e not b~en ;nanufactured by the contractor claImmg payment shall be mcluded In thIS Tariff and shall be deemed to be pharmaceutical requirements for its purposes only if they have been manufactured by a manufacturer named in Part III of the Schedule to this Tariff: ·S.R. 1965/41 Amendment No. 1: S.R. 1969/240 138 Drug Tariff 1970 1970/18

Provided also that the following classes of material shall be excluded from this Tariff and shall not be deemed to be pharmaceutical require­ ments: (a) A substance or any combination of substances specified in Part II of 'the Sohedule to this Tariff where ordered for any purpose other than for the treatment of a patient's medical condition: (b) Aerosols and similar articles packed under pressure other than a preparation (if any) that is specified in Part II of the Schedule to this Tariff: (c) Electrode jellies: (d) Eye drops packed in single dose units other than those (if any) that are specified in Part II of the Schedule to this Tariff: ( e) Insect repellents and similar preparations: (f) Long acting preparations for oral use other than those (if any) that are specified in Part II of the Schedule to this Tariff: (g) Lozenges and similar products: (h) Plasters, madhine spread: (i) Pregnancy tests: (j) Preparations prescribed as foods: (k) Preparations prescribed for contraceptive purposes: (1) Proprietary medicines or proprietary articles (other than a product that is a pharmaceutical requirement elsewhere specified in this Tariff or a product to which clause 16 of this Tariff applies): (m) Shampoos (other than extemporaneously prepared medicated shampoos intended for the treatment of a patient's medical condition) : (n) Toilet preparations: (0) Tooth paste and powders.

4. Rules for standard-( 1) No claim by a contractor for payment in respeot of the supply of pharmaceutical requirements by him shall be allowed unless the requirements so supplied comply- (a) With the appropriate standards prescribed by regulations for the time being in force under the Food and Drug Act 1969; or (b) In the absence of any such standards, with the appropriate standards for the time being prescribed by the British Pharma­ copoeia; or ( c) In the 'absence of any of the standards prescribed by paragraph (a) or paragraph (b) of this subclause, then with the appro­ priate standards for the time being prescribed by the British Pharmaceutical Codex. (2) In the absence of any of the foregoing standards prescribed by subclause (1) of this clause, the grade or quality of the product supplied shall not be lower than that ordinarily used for medicinal purposes. (3) Where a medical practitioner indicates in a prescription the pharmaceutical requil1ement to be supplied by reference to a trade mark, trade name, or by reference to the name of its manufacturer, a contractor shall supply the pharmaceutical requirement specified in the prescription in the form so indica:ted and not in any other form unless the prescribing practitioner has sanctioned a change. 1970/18 Drug Tariff 1970 139

5. Prices for pharmaceutical requirements-(I) Subject to the pro­ visions of clause 18 of this Tariff, payment shall be made in respect of claims for pharmaceutical requirements in accordance with the prices specified in the First Schedule to the Prescription Pricing Schedules and in accordance with the rules for pricing contained in Part II of this Tariff. (2) Subject to the provisions of clause 18 of this Tariff, where the price of any pharmaceutical requirement is not specified as provided in subclause (1) of this clause, payment shall be made in accordance with the rules contained in Part II of this Tariff. (3) Any amendment to the Prescription Pricing Schedules shall come into force on the 1st day of April, August, or December, or such other date as may be recommended by the appropriate committee, and payment in respect of any claims for pharmaceutical requirements, whatever their date, received by a Medioal Officer of Health on or a:fter the 16th day following the effective date of the amendment shall be calculated in accordance with the prices specified in that amendment. (4) Subject to subclauses (5) and (6) of this clause, if any pharmaceutical requirements are supplied to a patient as pharmaceu­ tical benefits, they shall be so supplied free of charge to the patient, except that, if the requirements are to be delivered to the patient elsewhere than at the pharmacy or other place of business of the contractor, a reasonable charge in accordance with subclause (2) of regulation 14 of the regulations may be made for t!he delivery. (5) Notwithstanding anything in subclause (4) of this clause, a con­ tractor may charge a customer with- (a) The price of any pharmaceutical requirements that are supplied by him in excess of the maximum quantities specified in this Tariff; or (b) The excess of the price of any proprietary preparation (being 'a preparation that is specifically ordered by a medical practi­ ltioner and supplied by the contractor) above the amount payable as calculated in accordance with the Prescription Pricing Schedules and the rules for pricing contained in this Tariff. (6) Notwithstanding anything in subclause (4) of this clause, a con­ tractor may charge a customer 5c in respect of any prescription dispensed at any time not within the ordinary hours of shop trading in the locality where the contractor carries on business.

PART II-RULES FOR PRICING 6. Application of rules for pricing-( 1) Subject to the discount pro­ vided for in clause 18 of this Tar,iff, or, in the case of 'a pharmaceutical requirement supplied by a medical practitioner, the discount of 10 per­ cent provided for in subsecition (1) of section 95 of the Socral Security Act 1964, the prices of pharmaceutical requirements supplied pursuant to the regulations shall be determined in accordance with the rules for pricing contained in this Part of this Tariff. (2) Where the computation is within plus or minus one half of one percent of the correct net amount payable to a contractor in respect of the claim concerned, then notwithstanding tJhat computation, payment to a contractor shall be made and accepted by him in full satisfaction of his claim against the Department for payment. 140 Drug Tariff 1970 1970/18

(3) In the event of a dispute between a contractor and a Medical Officer of Health concerning payment to a contractor, the contractor may apply in writing to the Medical Officer of Health dealing with his claims who shall, on receipt of the application, refer it to the appropriate committee for consideration and recommendation. The committee shall then consider the application and on coming to a decision shall notify the Medical Officer who shall then notify it in writing to the contractor. 7. Prescription pricing-Payment for each prescription shall be cal­ culated by adding together the following: (a) The total selling price of the ingredients: (b) The average container charge specified in the Second Schedule to the Prescription Pricing Schedules: (c) Without limiting paragraph (b) of this clause, where, pursuant to any appropriate prescription, the pharmaceutical require­ ments are prescribed or supplied in a dropper bottle, metal tube, or other approved container, the amount from time to time specified in the Second Schedule to the Prescription Pricing Sdhedules: (d) The appropriate dispensing fee as set out in the Third Schedule to the Prescription Pricing Schedules. 8. Computation of selling price-( 1) The selling price shall be deter­ mined on the basis of the price charged to contractors for the pharmaceutical requirement in such units as are customarily purchased by a contractor and at such prescription wholesale prices as are approved from time to time by the Commission. Where necessary, any such prices shall be converted to retail prices in the metric system. (2) The principal divisions of the metric system for the calculation of the selling price of any pharmaceutical requirement shall be 1 gram or 1 millilitre or a specified number, or a specified pack. (3) If a pharmaceutical requirement can be purchased in quantities other than in the quantities specified in subclause (2) of this clause, the selling price shall be calculated in the appropriate ra;tio to those quantities. (4) Where a liquid is purchased by weight and is dispensed by volume, an appropriate adjustment, based on the specific gravity of the liquid, shall be made in computing the retail price. (5) All computations concerned with quantities of pharmaceutical requirements that are specified in the Schedule to this Tariff shall be made in the metric system: Provided that, in the case of a pharmaceutical requirement that is prescribed or ordered in 'terms other than those of the metric system, computations shall follow the Apothecaries to Metric Conversion Tables for the time being approved for this purpose by the Minister. (6) Where a prescription for an injection orders the supply of a dry pack of a pharmaceutical requirement together with one or more ampoules or vials of a sterile diluent, payment for the composite items shall be made as for one prescription. (7) Where, for special reasons concerned with the protection of the patient, a medical practitioner directs on the prescription that a pharmaceutical requirement is to be dispensed daily or at such other regular intervals as he considers necessary, payment shall be made by 1970/18 Drug Tariff 1970 141 adding together the total selling price of the quantity of the pha~a­ ceutical requirement dispensed on each occasion, and the appropriate dispensing fee; but the Department may in its discretion refuse to pay the container allowance in respect of any second or subsequent dispensing. (8) Where the strength of a preparation is not indicated on a prescription the contractor shall endorse thereon the strength supplied. Otherwise payment shall be based on the price ofvhe lowest strength available. 9. Items not listed in the First Schedule to the Prescription Pricing Schedules-( 1) In the case of items not listed in the First Schedule to the Prescription Pricing Schedules, the selling price shall be com­ puted by adding together the following: (a) The price charged to the contractor (without sales tax): (b) 20 percent of the price specified in paragraph (a) of this subclause: ( c) Any sales t'ax. (2) Where necessary the price so computed shall be converted to the nearest appropriate metric amount specified in clause 8 (2) of this Tariff.

10. Items dispensed by count-( 1) Where items dispensed by count are listed in the First Schedule to the Prescription Pricing Schedules, the selling price of the number dispensed shall be calculated as an exact numerical proportion of the selling price shown in that Schedule. (2) Where items dispensed by count are not listed in the First Schedule to the Prescription Pricing Schedules, the selling price shall be computed by adding together the following: (a) The price charged to the contractor (without sales tax): (b) 20 percent of the price specified in paragraph (a) of this subclause: ( c) Any sales tax. (3) Broken quantities shall be computed as an exact numerical proportion of the retail price.

11. Official requirements not in the First Schedule to the Prescription Pricing Schedules-Where any pharmaceutical requirement (being a requirement included in the British Bharmacopoeia, the British Pharmaceutical Codex, or the British National Formulary, but nat one included in the First Schedule to the Prescription Pricing Schedules) is purchased as a ready made preparation, a contractor shall claim by stating in writing the cost price and source of supply. In any other case the prescription shall be priced in accordance with the rules for pricing contained in this Part of this Tariff.

12. Rounding calculations-Calculations for the price of each ingredient are to be rounded to the nearest cent, but exact half cents are to be so expressed. The final half cent is to be rounded upwards to the nearest cent.

13. Minimum charges-(l) The minimum charge for any ingredient in a mixture shall be lc. 142 Drug Tariff 1970 1970/18

(2) The minimum total charge for all ingredients in a mixture shall be 5c: Provided that where the total selling price of all the ingredients, including any that are not specified in this Tariff, exceeds 5c, pay­ ment shall be made for the total value of the requirements that are specified in this Tariff rounded upwards to the nearest cent. (3) For the purposes of this clause the term "mixture" means a.ny prescribed preparation requiring the admixture of two or more m­ gredients, including a vehicle or excipient.

14. Water-( 1) Where the term "aqua" is used in a prepamtion with­ out qualification, it shall be interpreted to mean wholesome drinking water. (2) Distilled water shall be oharged for only where specified on the prescription or where its use is necessary in conformity with standard dispensing practice. (3) Water for injection may be charged for where the contractor certifies in the prescription that the water was supplied for the purpose. ( 4) Wholesome drinking water shall not be an ingredient bearing a charge on a prescription.

15. Bulk supply orders and medical practitioners' supply orders­ (1) Payment for bulk supply orders and medical practitioners' supply orders shall be computed as follows: (a) By adding 50 percent to the prescription wholesale price specified in the First Sohedule to the Prescription Pricing Schedules: Provided that only 20 percent shall be added in the case of allergy treatment sets, insullin preparations, or radiographic preparatory substances: (b) Subject to paragraph (a) of this subclause, where the quantity of any pharmaceutical requirement that is supplied exceeds the wholesale unit for the time being specified in the First Schedule to 'the Prescription Pricing Sohedules, payment shall be based on the appropriate wholesale rate: Provided that a contractor may receive payment based on his statement of the cost price of the requirement to him and his source of supply so long as the amount payable therefor does not exceed that which would be payable had the said wholesale units (or parts thereof) been supplied: (c) No payment shall be made for containers supplied with materials ordered on a bulk supply order for a hospital or other approved institution unless the order specifies 'that a pharmaceutical requirement is to be dispensed in metal tubes, dropper bottles, or other approved containers, in whioh case the appropriate sum specified in the Second Schedule to the Prescription Pricing Schedules shall be paid for those oontainers: (d) Where any pharmaceutical requirement ordered on a medical practitioner's supply order is supplied in a dropper bottle, metal tube, or any other approved container, the sum specified in the Second Schedule to the Prescription Pricing Schedules shall be paid for that: dropper bottle, metal tube, or other approved container, as the case may be: 1970/18 Drug Tariff 1970 143

(e) No payment shall be made for a dispensing fee, except in the case of a pharmaceutical requirement compounded by the contractor. (2) Before any discount provided for in this Tariff is deducted, there shall be deducted fromuhe

16. Proprietary preparations-(1) If any prescrIptIon orders a pro­ prietary preparation that is identical in composi1uon to 'a pharmaceutical requirement specified in this Tariff or is deemed by the Director-General to be identical to a requirement so specified, payment shall be made in accordance with the rules for pricing contained in this Part of this Tariff: Provided that, in the case of any requirement listed in ,the table of allowances specified in the Prescription Pricing Schedules, only partial payment may be made, and then only on the advice of the appropriate committee. (2) Any payment made or to be made to a contractor pursuant to subclause (1) of this clause shall be accepted by him in satisfaction of the price of any pharmaceutical requirement referred to in that sub­ clause to the extent of that payment.

17. Rectified spirit-When is prescribed for use in pharma­ ceutical requirements that are used as external preparations, payment shall be made only for industrial methylated spirits, unless the medical practitioner has specified ,that rectified spirit is to be used.

PART Ill-MISCELLANEOUS PROVISIONS 18. Claims on the Department-( 1) Pursuant to regulation 14 of the regulations, a contractor may submit claims for payment in respect of pharmaceutical requirements supplied by him during half-monthly or monthly periods. (2) Where the claim relates to or includes any prescription or order which was last dispensed more tihan 3 months before the date on which the claim is first received by the Medical Officer of Health, the amount due to the contrac1Jor in respect of every such prescription or order so dispensed shall, unless the contractor satisfies the Medical Officer of Health that he has a reasonable excuse for his delay in sub­ mitting the claim, and subject to any general or special directions given by the Director-General, be reduced by a discount of 10 percent: Provided that the amount due shall not be reduced by 'the said discount in any case where a prescription is endorsed "extended supply" and is fulfilled in part only and is received by the Medical Officer of Health for payment within 6 months of the date of initial dispensing.

19. Allergy treatment sets-( 1) Payment in respect of an ,allergy treatment set allowed under this Tariff shall be the amount specified from time to time in the Prescription Pricing Schedules or the amount approved from time to time by the Director-General. 144 Drug Tariff 1970 1970/18

(2) In the case of a person for the time being approved by the Director-General as the manufacturer of approved allergy treatment sets, the amount payable in respect of any allergy treatment set supplied by him shall be the amount approved from time to time by the Director-General. (3) In the case of a contractor, the amount payable in respect of any allergy treatment set supplied by him shall be computed by adding together the cost price of the set, 20 percent of the cost price, and the appropriate dispensing fee. 20. Intravenous fluids-Payment to ;a licensed hospital or to a medical practitioner in respect of the types of intravenous fluids allowed under 'the Schedule to this Tariff shall be the amount of the allowance specified from time to time in the Prescription Pricing Schedules or the sum approved from time to time by the Director-General. 21. Payment for anaesthetic gases-Payment to a medical practitioner in respect of a gas specified in the Schedule to this Tariff shall be at the rate of $0.60 for each occasion when an anaesthetic is administered con­ taining that gas: Provided that if an anaesthetic contains more than one gas specified in the Schedule to this Tariff payment shall be made in respect only of one gas contained in that anaesthetic as if that one gas and no other gas were used on that occasion.

22. Period and quantity of supply-( 1) Payment may be made pursuant to anyone prescription for a quantity of the pharmaceutical requirement so prescribed sufficient to provide treatment for a period not exceeding 7 days in respect of the original supply and a further 7 days in respect of the repeat: Provided that, on the contractor supplying a lesser or greater quantity than that prescribed and endorsing the prescription accordingly, payment shall be made to him in respect of the amount so supplied if the quantity prescribed does not coincide with an original pack and the requirement is packed in a collapsible tube, dropper bottle, or other special container from which it is not practicable to dispense the exact quantity. (2) Notwithstanding anything to the contrary in subclause (1) of this clause, where any prescription prescribes any pharmaceutical requirement to which the restriction " restriction" applies, payment may only be made in respect of that prescription (which may provide for a repeat) to the extent that it prescribes sufficient of the requirement to provide a person with treatment for a period not exceeding 7 days. (3) Notwithstanding anything in paragraph (a) of the proviso to subclause (1) of this clause, in any case where the liquid oral form of a pharmaceutical requirement is prescribed, and either the restriction "antibiotic restriction" or "penicillin restriction" applies, payment shall be made for- (a) The exact numerical proportion of the bulk pack if such a pack is available; or (b) The next smallest pack or the next smallest number of packs, as the case may be, if the quantity prescribed does not coincide with a standard pack and a bulk pack is not available; or 1970/18 Drug Tariff 1970 145

(c) The next largest pack if the quantity prescribed does not coincide with a standard pack and neither a bulk pack nor a smaller pack is available: Provided that, in any case where the pharmaceutical requirement is ordered as an injection and the restriction "antibiotic restriction" applies, payment may only be made for a quantity sufficient for a period not exceeding 72 hours' treatment. (4) Notwithstanding anything in subclause (1) or subclause (3) of this clause, where a quantity is specified in the availability column of Part II of the Schedule to this Tariff, it refers to the maximum quantity of the pharmaceutical requirement for which payment may be made on each occasion that the requirement is dispensed, either on the original dispensing of the requirement or on the dispensing of any repeat. The restriction of availability to "one pack" or "one tube" shall not apply to a medical practitioner's supply order or to a bulk supply order. (5) NotwithS'tanding anything in subclauses (1) to (4) of this clause, where, in the opinion of the prescribing medical practitioner, extended treatment is necessary for a period of not less than 1 mouth and no danger is involved in the use of a pharmaceutical requirement without medical supervision, a supply of that pharmaceutical requirement not exceeding a quantity sufficient to provide that person with treatment for a specified period of 1 month in the case of a narcotic or from 1 to 3 months in any other case may be made on anyone prescription; and, if the medical practitioner has endorsed the prescription with the words "extended supply" and has specified on it the period for which that pharmaceutical requirement is to be supplied, payment shall be made in respect of a claim made accordingly: Provided that in any case where a patient is receiving an extended supply of any pharmaceutical requirement, that requirement shall be dispensed in monthly lots, unless- (a) The prescribing medical practitioner endorses the prescription with a statement of the period for which each lot is to be dispensed; or (b) The contractor or the patient endorses the back of the pre­ scription with a statement of the special reasons why a quantity greater or less than a monthly lot is required to be dispensed. (6) Any prescription that is nd!: presented to a contractor for dis­ pensing within 4 days of its being written in the case of a narcotic, or within 3 months of its being written in any other case, shall cease to be a charge to the Department. (7) A repeat on a prescription that remains unfulfilled after 1 month from the date of first dispensing of any requirement named in the pre­ scription shall cease to be a charge to the Department. The contractor concerned may submit a claim for part fulfilment of the total quantity ordered in respect of the part that is due for payment. (8) A repeat on a prescription endorsed "extended supply" that remains unfulfilled after 3 months from the date of first dispensing of any requirement named in the prescription shall cease to be a charge to the Department. The contractor concerned may submit a claim for the part fulfilment of the total quantity ordered in respect of the part that is due for payment, and payment shall be made accordingly. 146 Drug Tariff 1970 1970/18

23. Bulk supply orders-( 1) Notwithstanding anything in this Tariff, the licensee or manager of a licensed hospital or the matron or other person in charge of an institution approved by the Director-General may obtain, pursuant to a bulk supply order on a form to be supplied by the Department, suoh pharmaceutical requirements as he expects will be required for the treatment of persons who are under medical super­ vision in that hospi:tal or approved insttitution: Provided that- (a) Payment shall not be made for any requirement that is specifically restricted in the Schedule to this Tariff: (b) The licensee or manager or, as the case may be, the matron or other person may be called upon to jus'tify the amount ordered: (c) No narcotic shall be obtained on a bulk supply order by any institution which is not a licensed hospital or which is not an institution or place recognised and approved as a hospital for the purposes of Part II of the Social Security Act 1964: (d) No item listed in the Seventh Schedule to the Poisons Regulations 1964* shall be obtained on a bulk supply order by any institu­ tion which is not a licensed hospital or which is not an institu­ tion or place recognised and approved as a hospital for the purposes of Part II of the Social Security Act 1964, unless- (i) A registered nurse is employed by the institution; and (ii) The order is supported by a written requisition signed by a medical practitioner. (2) Payment shall be made to the contractor on the presentation of the appropriate copy of a bulk supply order form supplied by the Department which- (a) Sets forth the pharmaceutical requirements which have been supplied; and (b) Has endorsed on it a receipt, signed and dated by the licensee or manager or, as the case may be, the matron or other person, indicating tha:t the requirements have been received by him: Provided that a special form, also provided by the Department, shall be used in the case of an order for the bulk supply of a narcotic. (3) The quantities ordered on a bulk supply order are to be limited to those quantities that are sufficient to meet reasonable needs for a period not exceeding 1 month, after taking into account stock on hand rat the time of preparing the requisition. (4) The Minister may at any time, by notice given in such manner as he thinks proper, declare that any hospital or other approved institu­ tion shall not be entitled to obtain supplies of pharmaceutical require­ ments under this clause; and on the making of any such declaration this clause shall cease to apply with respect to that hospital or other approved institution. Any such notice may in like manner be revoked.

24. Medical practitioners' supply orders-( 1) Notwithstanding any­ thing in this Tariff, a medical practitioner may obtain, pursuant to a medical practitioner's supply order, such pharmaceutical requirements as he expects to be -required for personal administration to patients under his care, if the quantities o-rdered are reasonable for up to 1 month's supply in the conditions obtaining in his practice; but no payment will *S.R. 1964/64 1970/18 Drug Tariff 1970 147 be made for any pharmaceutical requirement that is specifically restricted in the Schedule to this Tariff. The medical practitioner may be called upon to justify the amounts ordered. (2) Payment shall be made to the contractor on the presentation of the medical practitioner's supply order if at the time of supply it­ ( a) Is signed personally by the medical practitioner: (b) Is dated in the medical practitioner's own handwriting: (c) Sets out the pharmaceutical requirements (not being requirements that may only be supplied by a Hospital Board) that the medical practitioner requires at the time: ( d) Has endorsed on it a receipt signed and dated by the medical practitioner, or his agent, in respect of the requirements supplied. Any order for a narcotic shall be written on a fonn to be supplied by the Department. (3) A medical practitioner may, except in exceptional circumstances, order only those pharmaceutical requirements that he requires to ad­ minister personally to a patient or requires for emergency use until a supply can be obtained by the patient pursuant to 'a prescription. ( 4) The Minister may at any time, on the recommendation of the Medical Services Advisory Co~ttee appointed under Iseation 121 of the Social Security Act 1964, by notice given in such manner as he thinks proper, declare Ithat any mediaal practitioner whose name is specified in the notice shall not be entitled Ito obtain suppl!ies of pharma­ ceutical requirements under this clause; and on the making of any such declaration this clause shall cease to apply with respect 'to that practi­ tioner. Any such notice may in like manner be revoked.

25. Revocations and savings-( 1) The foHowing dilfeotions are hereby revoked: Title Serial Number The Drug Tariff 1967 1967/143 The Drug Tariff 1967, Amendment No. 7 1969/226 (2) WithoUlt limiting the provisions of the Acts Interpretation Act 1924, it is hereby declared that the revocation of any provision by this direction shall not affect any document made O'r anything whatsoever done under the provision so revoked or any corresponding former provision, and every such document or thing, so far as it is subsisting or in force at the time of Ithe revocaJtion land could have been made or done under this direction, shall continue and have effect as if it had been made or done under the corresponding provision of this direction and as if :that provision had been in force when the document was made or the ithing was done. 148 Drug Tariff 1970 1970/18

SCHEDULE

LIST OF PHARMACEUTICAL REQUIREMENTS FOR WmCH PAYMENT IS ALLOWED OR CONDITIONALLY ALLOWED

PART !-DEFINfrrONS 1. "Anaesthetic gases" means that payment will be made to a medical practitioner who has administered the gas to a person who is neither an inpatient of a public hospital nor a person for whom the anaesthetic service has been provided as part of 'a maternity benefit, if the amount specified in clause 21 has been credited to that person's account. 2. (1) "Antibiotic restriction" means the supply of the pharmaceutical requirement in accordance with clause 22 of this Tariff for the treatment of an - (a) Where the infection is resistant to penicillin or sulphonamides; or (b) Where a broad spectrum antibiotic is regarded by aUJthoritative medical opinion as the treatment of choice for the infection: Provided that, in the case of a prescription endorsed "extended supply", payment shall be made only where the requirement is used in :the treatment of a chronic respiratory condition or other chronic condition in which a broad spectrum antibiotic is regarded as the treatment of choice by authoritaitive medical opinion. (2) Any proprietary topical application of an antibiotic (other than a preparation that is specified in Part II of the Schedule) shall not be a charge to the Department. Where any quantity of any pharmaceutical requirement specified in this subclause, or its salts or derivatives, is present in any preparation compounded by a contraotor, not being a prepaiI'ation specified in Part II of this Schedule, it shall not be a charge to the Department. 3. "Approved condition" mearrs a pharmaceutical requirement sup­ plied pursuant to a prescription endorsed with the words "Approved condition" written in the practi'tioner's own handwriting or signed or initialled by the pract~tioner, and ordered for therapeutic purposes, but neither for contmceptive purposes nor as a pregnancy test. 4. "Dermatological specialist" means that payment may be made only when the pharmaceutical requirement concerned is ordered by a derma­ tological specialist; but, in Ithe case of treatment recommended by the dermatological specialist, ;the prescription of a medical practitioner endorsed with the words "recommended by [name of specialist]" shall be accepted for payment. S. "Hospital Board" means that payment may be made only when the pharmaceutical requirement concerned is 'supplied by a Hospital Board to an outpatient (being for the purposes of this T'ariff any person who is not an inmate of a public hospital) on the prescription of a medical practitioner. 6. "Hospital Board-specialist" means that the pharmaceutical requirement concerned may be supplied free of charge only by a Hospital Board ,to any person who is not an inpatient of a public hospital on the prescription of a specialist. Where treatment of any such person with the requirement has been recommended by a specialist and the requirement is prescribed by a medical practitioner, the prescription of ,the medical practJitioner endorsed with the words "recommended by [name of specialist]" shall be accepted by a Hospital Board and the requirement shall be supplied as aforesaid. 1970/18 Drug Tariff 1970 149

SCHEDULE-continued For the purposes of this definition it shall not make any difference whether the specialist is employed by the Board or not. 7. "Hospital Board-O. and G. speci:alist" means that the pharma­ ceutical requirement concerned may be supplied free of cbarge only by a Hospital Board to any person who is not an inpatient of a public hospital on the prescription of an obstetrical or gynaecological specialist. 8. "In combination" means .that the pharmaceutical requirement con­ cerned is allowed at the Department's expense only when included in a prescription in combination with other pharmaceutical requirements that are specified in this Schedule as being aVlailable otherwise than "in combination", and ,then only to the extent specified. 9. "Intravenous fluids" means that payment may be made only- (a) To ,a licensed hospital for the treatment of any patient in the hospital (being treatment that has been recommended by a medical pmctitioner), or if the requirement has been supplied by the hospital to a medical practitioner for the treatment of a patienit in his own home; or (b) To a medical practitioner who has used the requirement for the treatment of a patient either when 1reating him at a licensed hospital or at his home. 10. "Maternity hospital" means that payment shall be made only when the pharmaceutical requirement concerned is supplied, pursuant to a bulk supply order, to a maternity hospital licensed under the Hospitals Act 1957. (See clause 23 of this Tariff.) 11. "Midwifery order" means that payment may be made only when the pharrnaceuJtiaal requirement concerned is supplied in the specified quantity to a patient as an authorised midwifery requirement pursuant to a midwifery order signed by the hospital Hcensee or manager of a private hospital within the meaning of the HospiJtals Act 1957, or by a midwife or maternity nurse registered under the Nurses and Midwives Act 1945, as the case may be. 12. "Ophthalmological specialist" means that payment may be made only when the pbarmaceUltical ,requirement concerned is ordered by an ophthalmological specialist (including the registrar of the appropriate department of a public hospital) for the treatment of any medical condition affecting the eye; bUlt, in ,the case of treatment recommended by the specialist, the prescription of a medical practitioner endorsed with the words "recommended by [name of specialist]" shaH be accepted for payment. 13. "Otolaryngological specialist" means that payment may be made only when the pharmaceutical requirement concerned is ordered by an otolaryngological specialist (including the registrar of tthe appropriate department of a public hospital) for the treaJtment of any medical condition affecting the ear, nose, or throat; but, in the case of treatment recommended by the specialist, the prescription of a medical practitioner endorsed with the words "recommended by [name of specialist]" shall be accepted for payment. 14. (1) "Penicillin restriction" means the supply of penicillin, in accordance with clause 22 of this Tariff; but in the case of a prescription for penicillin which is endorsed "extended supply", payment may be made only when the penicillin is used in the treatment of conditions in which is it regarded as the treatment of choice by authoritative medical opinion. 150 Drug Tariff 1970 1970/18

SCHEDULE-continued (2) Any topical preparation of penicillin other than a preparation that is specified in Pal1t 11 of Ithis Schedule shaH not be a charge to the Department. 15. "Psychiatric specialist" means that payment may be made only when the pharmaceutical requirement concerned is suppIied pursuant to la medical practitioner's supply order signed by a medical practitioner engaged in the practice of psychiatry. 16. Only those medical praotitioners who for the purposes of section 97 of the Social Security Act 1964 (as substituted by section 14 of the Social Security Amendment Act 1969) have been recognised as specialists by the Minister shall be specialists for the purposes of this Schedule and then only to the extent of the medical or surgical speciality in which they are so recognised.

PART II Availabil9J

Code Pharmaceutical Requirement Reference I Availability

aaa Acacia In combination. aad aag Acetarsol pessaries, compound aaj Acetazolamide and its salts aam aal Acetohexamide aap Acetomenaphthone aas Acetone (a) Not available on a medical practitioner's supply order. (b) Not available on a bulk supply order. aau chloride eye drops aby Aconite, belladonna, and chloroform liniment, B.P.C. abz Aconite liniment, RP.C. aea Acriflavine aed Adrenaline acg Adrenaline acid tartrate ach Adrenaline acid tartrate aerosol in­ haler acj Adrenaline and spray, com­ pound, B.P.C. add Adrenaline acid tartrate, compound, eye drops .• •• aco Adrenaline hydrochloride .• acr Adrenaline hydrochloride aerosol in- haler aep Adrenaline mucate aes Agar .. aev Alcohol In combination, not exceeding 50 ml. acw Alcohol, dehydrated, for injection acx Alcuronium chloride injection ad Alginic acid acz Alkaline compound tablets (milk­ As approved by the Director­ dextrin type) .. General of Health. ada Allergy treatment sets As approved by the Director­ General of Health. adb Allopurinol tablets ade Allyloestrenol 1970/18 Drug Tariff 1970 151

SCHEDULE-continued

PART II-continued Availability-continued

Code Availability Reference I Pharmaceutical Requirement

adg Almond oil adm Aloes .. adv Aloin .. adw Aloxiprin tablets aea Alseroxylon aed Alseroxylon with pentaerthritol tetra­ nitrate tablets aeg Alum " aej Alum and dusting powder for in- fants, B.P.C. .. aem solution, B.P.C. aen Aluminium chloride aep Aluminium powder aeq Aluminium hydroxide and bella­ donna mixture, B.P.C... aex Aluminium hydroxide with magne­ sium carbonate compound gel, dried aes Aluminium hydroxide gel aev Aluminium hydroxide gel, dried aez Aluminium hydroxide gel with kaolin mixture aey Aluminium hydroxide gel with kaolin and pectin mixture afb Aluminium hydroxide gel with mag­ nesium hydroxide mixture afa Aluminium hydroxide gel dried with hydroxide tablets afc Aluminium hydroxide gel dried, with magnesium trisilicate and magne­ sium hydroxide tablets .. afn Aluminium magnesium silicate afd Aluminium paste, compound, B.P.C. afg Aluminium sodium silicate with bel- ladonna afj Aluminium sulphate afm Amaranth solution afp Amethocaine hydrochloride afs Amethocaine eye drops, B.P.C. afv Aminacrine hydrochloride afw 9-Aminoacridine undecylenate with N-myristyl -3- hydroxybutylamine hydrochloride, methylbenzetho­ nium chloride and succinic acid vaginal tablets afX Aminocaproic acid Hospital Board-specialist. aga Aminophylline .. agd Aminophylline with ephedrine hydro­ chloride, and amylobarbitone cap­ sules .. agg Aminophylline with ephedrine hydro­ chloride, and amylobarbitone tab­ lets .. agh Aminophylline with ephedrine sul­ phate, and phenobarbitone tablets agj Aminophylline with aluminium hy­ droxide gel tablets 152 Drug Tariff 1970 1970/18

SCHEDULE-continued

PART II-continued

Availability----mntinU'ed

Code Pharmaceutical Requirement Availability Reference I

agm Aminopterin and its salts Hospital Board-specialist. ags Amisometradine .. agt hydrochloride agu Amitriptyline pamoate syrup agz Ammonia and ipecacuanha mixture, B.N.F. ahg Ammonia solution, aromatic, B.P.C. ahs Ammonia solution, dilute, B.P.C. ahd Ammonia solution, strong, B.P. ahj Ammonia spirit, aromatic, B.P.C. ahm Ammonium acetate solution, strong, B.P.C. ahp Ammonium bicarbonate .. .. i ahv Ammonium chloride ahz Ammonium chloride mixture, B.N.F. aia Ammonium chloride and morphine mixture, B.N.F. aid Amodiaquine hydrochloride aij Amphetamine sulphate aii Amphotericin-B lotion aik Ampicillin Penicillin restriction. aim Amyl nitrite aip Amylobarbitone ais Amylobarbitone sodium aiv Amylobarbitone sodium with quinal- barbitone sodium capsules aix Amylocaine hydrochloride ajn Angiotensin amide ajp Anise oil In combination. ajs Anise water In combination. ajt eye drops, compound, B.N.F.1963 ajv Antazoline hydrochloride Except in any topical application. ajz Antazoline mesylate Except in any topical application. ajw Antazoline sulphate and naphazoline nitrate aka Antimony potassium tartrate akd Antimony sodium tartrate akg Apomorphine hydrochloride akz Ascorbic acid and its sodium salt Except tablets exceeding 100 mg each. aks Aprotinin Hospital Board-specialist. akv Aqueous cream, B.P. aav Aspirin aaz Aspirin, soluble, tablets, B.P. aax Aspirin with caffeine tablets aay Aspirin with codeine phosphate tab­ lets .. aba Aspirin and opium tablets, com­ pound, B.P.C. abb Aspirin with paracetamol and codeine phosphate tablets abd Aspirin and phenacetin tablets, B.P.C. akn Aspirin, phenacetin and codeine tab­ lets, B.P. abp Aspirin tablets, compound, B.P.C... 1970/18 Drug Tariff 1970 153

SCHEDULE-continued

PART II-continued

Availability-con tinued

Code Availability Reference I Pharmaceutical Requirement

abr Aspirin soluble, tablets, compound, as approved by the Director-General of Health akw Aspirin soluble abs Aspirin with ipecacuanha and opium tablets, B.P.C. ala Atropine aId Atropine and cocaine eye ointment, B.P.C. alj Atropine methonitrate aIm Atropine sulphate aln Attapulgite with neomycin sulphate Hospital Board. alp Azapetine phosphate aIr Azathioprine Hospital Board-specialist. baa Bacitracin and its salts For injection only. bac Bacitracin and its salts and neomycin sulphate in proprietary prepara­ tions One pack. bad Bacitracin and neomycin proprietary eye ointment .. One tube. baf Bacitracin with neomycin sulphate and polymyxin B sulphate proprie­ tary preparations One pack. bav Barbitone sodium baz Barium sulphate bbc Beclamide Hospital Board-speciali:,t. bas Beclomethasone dipropionate cream exceeding 0.025% strength Dermatological specialist. bbb Beclomethasone dipropionate proprie­ tary cream, lotion or ointment, with or without chlortetracyline, or neomycin sUlphate .. bay Beclomethasone dipropionate with lignocaine rectal ointment and sup­ positories bba Beeswax, white bbd Beeswax, yellow .. bbf Belladonna, prepared bbg Belladonna =tract, dry, B.P. bbm Belladonna extract, liquid, B.P.C. bbs Belladonna liniment, B.P.C. bbv Belladonna tincture, B.P. bca Belladonna and ephedrine mixture for infants, B.N.F. bcd Belladonna and ipecacuanha mixture for infants, B.N.F. bcg Belladonna mixture for infants, B.N.F. bcj Belladonna and phenobarbitone tab­ lets, B.P.C. bcm Bemegride bcp B-naphthyl-di (2-chloropropyl)- amine (R 151) with urethane Hospital Board--specialist. bct Bendrofluazide .. bcr Bendrofluazide with reserpine and po­ tassium chloride tablets bcu Bendrofluazide with potassium chlor­ ide tablets 154 Drug Tariff 1970 1970/18

SCHEDULE-continued

PART II-continued Availability-conttinueld

Code Pharmaceutical Requirement Availability Reference I

bcv Benedict's solution (qualitative) (a) Not available on a medical practitioner's supply order. (b) Not available on a bulk supply order. bda Benethamine penicillin injection bdd Benethamine penicillin oral prepara- tions .. Penicillin restriction. bdg Bentonite bah Benzaldehyde bdi Benzaldehyde spirit, B.P.C. bdj Benzalkonium bromide solution, B.P.C. bdl Benzalkonium chloride jelly as approved by the Director-General of Health bdm Benzalkonium chloride solution, B.P.C. bdn Benzalkonium chloride tincture bds Benzathine penicillin injection bdv Benzathine penicillin and its salts for oral use Penicillin restriction. bdz Benzhexol hydrochloride .. bea Benzocaine bec Benzocaine injection, compound bef Benzocaine ointment, compound, B.P.C. beg Benzocaine suppositories, compound, N.Z.F. 1953 .. bej Benzoic acid bek Benzoic acid solution, B.P.C. bem Benzoic acid ointment, compound, B.P.C. bep Benzoin bev Benzoin inhalation, B.P.C. bez Benzoin tincture, B.P.C. .. bfa Benzoin tincture, compound, B.P.C. bfg Benztropine mesylate tablets bfj Benzyl alcohol .. bfm Benzyl benzoate bfp Benzyl benzoate application, B.P. bfs Benzylpenicillin and its salts Penicillin restriction. bfv Benzylpenicillin and its salts for in- jection bfw Benzylpenicillin and its salts, with or without procaine penicillin, bene­ thamine penicillin, or benzathine penicillin, for injection .. bft Benzylpenicillin ear drops, eye drops, nasal drops and pessaries bfu Benzylpenicillin eye ointment One tube. bfd Benzylpenicillin solution-tablets, buf- fered, B.P.C... bfr Benzylpenicillin sodium salt, purified, injection Hospital Board-specialist. bfy Bephenium hydroxynaphthoate bgc Betamethasone and its salts and esters as injections or tablets •. Hospital Board-specialist. 1970/18 Drug Tariff 1970 155

SCHEDULE-continued

PART II-continued Availability-continued

Code Availability Reference Pharmaceutical Requirement

bgb Betamethasone and its salts and esters, with or without neomycin sulphate when supplied in the form of pro­ prietary eye preparations, as ap­ proved by the Director-General of Health Ophthalmological specialist. bgk Betamethasone and its salts and esters, with or without neomycin sulphate when supplied in the form of pro­ prietary ear, nose or throat prepar­ ations, as approved by the Director­ General of Health bfz Betamethasone with betamethasone sodium phosphate, intra-articular injection bge Betamethasone sodium phosphate pellets bgl Betamethasone sodium phosphate with neomycin sulphate and napha­ zoline nitrate nasal spray bgh Betamethasone valerate with or with­ out neomycin sulphate or clioqui­ nol, as skin preparations bgt Betamethasone valerate scalp lotion bgu Betamethasone valerate with phenyl­ ephrine hydrochloride and ligno­ caine hydrochloride rectal ointment bgi Bethanidine sulphate bgd Bisacodyl bgg Bismuth carbonate bgs Bismuth powder, compound, RP.C. bgx Bismuth salicylate bha Bismuth subgallate bhd Bismuth subgallate suppositories, compound, RP.C. bhb Bismuth subgallate, compound, sup­ positories, as approved by the Director-General of Health bhg Bismuth subnitrate bhj Black currant syrup, B.P.C. In combination. bhm Blood volume expanders and elec- trolyte solutions Intravenous fluids. bhp Borax .. bhv Borax glycerin, B.P.C. 1959 bia Boric acid bif Brilliant green .. big Brilliant green and paint, B.P.C. bim Bromodiphenhydramine hydrochlo­ ride .. Except in any topical application. bin maleate elixir, tablets and long-acting tablets biq with brobenzoxaldine tablets bis Buchu infusion .. biv Buffered cream, B.P.C. biz Burnt sugar 156 Drug Tariff 1970 1970/18

SCHEDULE-continued

PART II-continued

Availability-continued

ReferenceCode I Pharmaceutical Requirement Availability

i>ja Busulphan Hospital Board-specialist. bjd Butacaine sulphate bje Hospital Board-specialist. bjg Butobarbitone bjj Butobarbitone with pentobarbitone tablets cab Cachet shells When dispensed with materials within this Drug Tariff. caa Cade oil cac Caffeine cag Caffeine iodide elixir, B.P.C. caj Caffeine with sodium iodide cao Cajuput oil cas Calamine cav Calamine colloidal caz Calamine application, compound, B.P.C. cba Calamine cream, B.N.F. cbd Calamine lotion, B.P. cbg Calamine lotion, oily, B.P.C. cbj Calamine ointment, B.P.C. cbm Calamine and coal tar ointment, B.P.C. cbp Calciferol cbs with vitamin D ~, B.P.C. cbz Calcium aurothiomalate injection .. ccb Calcium carbimide tablets cca Calcium carbonate ccd Calcium carbonate mixture for in­ fants, compound, B.P.C. cce Calcium carbonate powder, com- pound, B.N.F. ccf Calcium carbonate with glycine ccg Calcium chloride cci Calcium cyclamate In combination. ccj Calcium gluconate ccm Calcium gluconate injection, B.P. ccp Calcium gluconate with calciferol tablets ccq Calcium glucono-galacto-gluconate .. Hospital Board. ccv Calcium hydroxide cda Calcium lactate .. cdb Calcium lactate-gluconate tablets Hospital Board. cdg Calcium phosphate cdj Calcium sodium lactate .. cdp Camphor cds Camphor liniment, B.P... cdv Camphor liniment, ammoniated, B.P.C. cea Camphor spirit, B.P.C. 1959 ced Camphor water, B.P.C. ceg Capsicum oleoresin, B.P.C. cej Capsicum ointment, B.P.C. cem Capsicum tincture, B.P.C. cep Capsules, empty gelatin .. When dispensed with materials within this Tariff. 1970/18 Drug Tariff 1970 157

SCHEDULE-continued

PART II-continued Availability-oontinued

Code I Reference Pharmaceutical Requirement I Availability

ces hydrochloride cev Caraway oil cex Caraway water In combination. cez cfb Carbamazepine tablets cfa Carbenicillin Hospital Board-specialist. cfc Carbenoxolone sodium tablets Hospital Board-specialist. cfd Carbimazole cfp Carbromal cfs tincture, aromatic, B.P. C. cfv Cardamom tincture, compound, B.P. cfz Carmine cga Cascara extract, dry, B.P. cgd Cascara elixir, B.P. cgg Cascara extract, liquid, B.P. cjg Cascara and belladonna mixture, B.P.C. cjp Castor oil cjv Catechu tincture, B.P.C. cjw Cephaloridine Hospital Board-specialist. cjz Cetomacrogol 1000 ckb Cetomacrogol cream, B.P.C. cka Cetomacrogol emulsifying ointment, B.P.C. ckd Cetomacrogol emulsifying wax, B.P.C. ckg Cetostearyl alcohol ckj Cetrimide ckm Cetrimide emulsifying ointment, B.P.C. ckp Cetrimide emulsifying wax, B.P.C... cks Cetrimide cream, B.N.F... ckv Cetrimide with chlorhexidine, its salts or esters ckw Cetrimide with chlorhexidine hydro­ chloride cream (a) On the prescription of a medical practitioner. (b) Maternity hospital. (c) On a bulk supply order. ckz Cetyl alcohol cla Chalk .. eld Chalk mixture for infants, B.N.F. elg Chalk and opium mixture, B.N.F. elj Chalk powder, aromatic, B.P.C. elm Chalk powder, aromatic, with opium, B.P.C. elp Charcoal elz Chloral hydrate .. cmg Chloral elixir for infants, B.N.F. cmj Chloral mixture, B.N.F. .. cmm Chloral mixture for infants, B.N.F... cmm Chloral syrup, B.P.C. cmp Chlorambucil Hospital Board-specialist. cms Chloramine cmv , its salts and esters Antibiotic restriction. cna Chloramphenicol ear drops cnd Chloramphenicol ear insufflation cng Chloramphenicol eye drops 158 Drug Tariff 1970 1970/18

SCHEDULE-continued

PART II-continued

Availability-continued

Code I Reference Pharmaceutical Requirement Availability

cnj Chloramphenicol eye ointment One tube. cnm Chloramphenicol cinnamate Antibiotic restriction. cnp Chloramphenicol palmitate Antibiotic restriction. cnq Chloramphenicol pessaries and sup- positories cno Chloramphenicol with hydrocorti­ sone and its salts as eye preparations Ophthalmological specialist. cnt Chloramphenicol with polymyxin B sulphate proprietary eye drops cnr Chloramphenicol and polymyxin B sulphate proprietary eye ointment One tube. cnu Chloramphenicol with polymyxin B sulphate and sodium phosphate proprietary eye drops Ophthalmological specialist. cns Chlorbutol cnv hydrochloride Except in any topical application. coc Chlordiazepoxide hydrochloride cnz Chlorhexidine, its salts and esters cod Chlorhexidine cream, B.P.C. coe Chlorhexidine gluconate obstetric cream (a) On the prescription of a medical practitioner. (b) Maternity hospital. (c) Midwifery order (210 rol). cog Chlorhexidine gluconate solution 5 percent (a) On the prescription ofa medical practitioner. (b) Maternity hospital. (c) Midwifery order (100 ml). (d) On the bulk supply order of a private hospital. cof Chlorinated lime coj Chlorinated lime and boric acid solu­ tion, B.P.C. com Chlorinated soda solution, surgical, B.P.C. con Chlorisondamine chloride cqp Chlormethiazole and its esters Hospital Board-specialist. cov Chlorocresol coz Chloroform In combination for topical appli­ cation or as an ingredient in a pre­ paration for oral administration. cpd Chloroform and morphine tincture, B.P.C. cpg Chloroform spirit, B.P. cnx Chloroform water In combination. cpj Chloroquine phosphate cpm Chloroquine sulphate cpp Chlorothiazide .. cps Hospital Board-specialist. cpv Chloroxylenol cpz Chloroxylenol solution, RP.C. cqb Chlorphenesin ointment, dusting powder and pessaries cqa Chlorpheniramine maleate Except in any topical application. 1970/18 Drug Tariff 1970 159

SCHEDULE-continued

PART II-continued Availability---amtinuw

ReferenceCode I Pharmaceutical Requirement Availability

cqc Chlorpheniramine maleate long acting tablets .. cqd hydrochloride cqe Chlorpropamide cqf .. cqg .. cqj Chlortetracycline, its salts and esters Antibiotic restriction. cqz Chlortetracycline eye ointment One tube. cqx Chlortetracycline suppositories, ex- temporaneously prepared cqr Chlortetracycline hydrochloride topi- cal preparations with or without other pharmaceutical require­ ments, when extemporaneously prepared cqy Chlorthalidone .. cqs Chlorthalidone with reserpine tablets cra theophyllinate crg Chorionic gonadotrophin .. ct:j Chromium trioxide crk Chymotrypsin injection Hospital Board-specialist. crm Cinchocaine crp Cinchocaine hydrochloride crr Cinnamic acid .• crs Cinnamon oil In combination. crt Cinnamon water In combination. crv Citric acid csa Citronella oil In combination. csg Clemizole hydrochloride Except in any topical application. csb Clioquinol cream, ointment and powder csc Clioquinol with sapamine tablets csh Clofibrate Hospital Board-specialist. csk Clomiphene citrate Hospital Board-O & G specialist. csj Clorexolone csd Clove oil csl Cloxacillin sodium Hospital Board-specialist. csm Coal tar, prepared, B.P.C. cst Coal tar paint, B.N.F. csv Coal tar paste, B.P.C. csw Coal tar and salicylic acid ointment, B.P.C. csx Coal tar and zinc ointment, B.P.C... csz Cocaine cta Cocaine and eye-drops, B.P.C. ctg Cocaine eye-drops, B.P.C. ctj Cocaine hydrochloride ctp Cocillana extract, liquid, B.P.C. cts Cocoa .. In combination. ctv Coconut oil In combination. ctw Coconut oil, fractionated, B.P.C. ctz Codeine phosphate cua Codeine linctus, B.P.C. cuk Codeine linctus for infants, B.P.C. cub Codeine mixture pediatric, B.P.C•.. cug Codeine phosphate syrup, B.P.C•.. 160 Drug Tariff 1970 1970/18

SCHEDULE-continued

PART II-continued

Availability-con tin ued

Code Availability Reference I Pharmaceutical Requirement I

cuj Codeine compound tablets, B.P. cun Cod- oil cus Cod-liver oil emulsion, B.N.F. cuv Coffee, prepared In combination. cuz Colchicine cva Colchicum extract, liquid, B.P. cvd Colchicum and sodium salicylate mix- ture, B.N.F. cvg Colchicum tincture, B.P... cvh Colistin and its salts and esters Hospital Board-specialist. cvi Colistin sulphate with neomycin sul- phate and acetate ear drops cvj Collodion cvm Collodion, flexible cwg Colophony cwm Congo red cwn Copper diagnostic tablets (a) 36 tablet pack, or packs to be supplied. (b) Not available on a medical practitioner's supply order. (c) Not available on a bulk supply order. cwp Copper sulphate cws Copper and zinc sulphates lotion, B.P.C. cwv Coriander oil cwz Corticotrophin Hospital Board-specialist. cxb Corticotrophin gelatin injection, B.P. Hospital Board-specialist. cxa Corticotrophin long acting Hospital Board-specialist. cxc Corticotrophin zinc hydroxide injec- tion, B.P. Hospital Board-specialist. cxd Cortisone and cortisone acetate Hospital Board-specialist. cxj Cortisone and its acetate for ophthal­ mic injection .. Ophthalmological specialist. cxp Cortisone and its acetate when sup­ plied as proprietary eye prepara­ tions .. Ophthalmological specialist. cxs Cottonseed oil (a) On the prescription of a med­ ical practitioner. (b) Midwifery order (100 ml). cxz Cresol .. cya Cresol and soap solution, B.P. cyd Crotamiton cyg Crotamiton cream cyj Crotamiton lotion cym Crystal violet cyp Crystal violet pessaries, B.P.C. cys Cyanocobalamin injection For parenteral use not exceeding 500 mcg per m!. cyy Cyclamic acid In combination. cyz Cyclandelate cza , its salts or esters czb Cyclizine tartrate with morphine tar­ trate injection .. czd Cyclobarbitone calcium czh Cvclopenthiazide 1970/18 Drug Tariff 1970 161

SCHEDULE-continued

PART II-continued Avaiiability-dOIlItmu'e!d

Code I Pharmaceutical Requirement Availability Reference

czn Cyclopenthiazide and guanethidine sulphate with potassium chloride tablets czk Cyclopenthiazide and potassium chlo­ ride tablets czi Cyclopenthiazide and reserpine with potassium chloride tablets czp hydrochloride eye­ drops not exceeding I percent strength Ophthalmological specialist. czl Cyclophosphamide Hospital Board-specialist. czj Cycloserine Hospital Board-specialist. czm Cycrimine hydrochloride .. czu hydrochloride Except in any topical applicatioi1. daa Dapsone dad Debrisoquine sulphate tablets dac Demecarium bromide Ophthalmological specialist. dah Demethylchlortetracycline Antibiotic restriction. dan Deoxycortone and its esters das chloride cream and pessaries dat Desferrioxamine mesylate Hospital Board. dav Dettol .. (a) On the prescription ef a medical practitioner. (b) Maternity hospital. (c) Midwifery order (100 ml). daz Dettol cream Maternity hospital: Midwifery order (I tube). dba Dexamethasone and its salts and esters Hospital Board-specialist. dbb Dexamethasone sodium phosphate injection In cases of acute emergency or for preoperative use; for refund on Form G.M.S. I or on a direct claim of a medical pratitioner, solely after use in a particular case. dbc Dexamethasone with framycetin and gramicidin proprietary eye prepar­ ations Ophthalmological specialist. dbe Dexamethasone with framycetin and gramicidin proprietary ear prepar­ ations dbd Dexamphetamine sulphate dbg Dextran injection Intravenous fluids. dbj Dextran sulphate Intravenous fluids. dbm Dextrochlorpheniramine maleate Except in any topical application. dbn Dextrochlorpheniramine maleate long acting tablets dbl Dextromoramide acid tartrate dbo Dextropropoxyphene hydrochloride capsules and tablets dbp Dextrose, RP. In combination. dbs Dextrose intravenous solutions (ster­ ile) Intravenous fluids. dbv Dextrose injection Available, all strengths, in containers not exceeding 50 ml capacity, in cases of hypoglycaemia. Con. Regs.-7 162 Drug T ariD 1970 1970/18

SCHEDULE-continued

PART II-continued A vailability-rontinu'eti

Code I Pharmaceutical Requirement Availability Reference

dpq Dextrose monohydrate dca Diamorphine hydrochloride } dcd Diamorphine linctus, B.P.C. Maximum quantity for oral use, dcg Diamorphine and terpin elixir, . 16 doses. B.P.C. dch Diazepam capsules, tablets and In- jections dcj Dibromopropamidine cream, RN.F. dcm Dibromopropamidine isethionate .. dcp Dibromopropamidine isethionate with diamidino-diphenylamine dihydro­ chloride otic solution dcq Dichloralphenazone tablets dcu Dichlorophen tablets dcw Dichlorphenamide Ophthalmological specialist. dcz Dicophane dda Dicophane application, B.P.C. ddd Dicophane dusting-powder, B.N.F..• ddj DicycIomine hydrochloride ddm Dienoestrol ddv Diethylcarbamazine citrate ded Digitalis, prepared, RP. .. dem Digitalis tincture, B.P.C. 1959 dep des dev Dihydroergotamine and its salts dfa Dihydrotachysterol dfb Dihydroxyaluminium sodium carbon- ate tablets dfd Di-iodohydroxyquinoline .. dfg Di-iodohydroxyquinoline compound, powder and vaginal tablets dfj Dill oil. . dfk Dill water dfl DiIoxanide furoate Hospital Board. dfm .. dfp Dimercaprol dfs Dimethicone dfv Dimethicone cream, RP.C. dfw Dimethicone creams as approved by the Director-General of Health .. dfz .. dgd Dioctyl sodium sulphosuccinate dge Dioctyl sodium sulphosuccinate with acetphenoIisatin suppositories dgg Dioctyl sodium sulphosuccinate with dihydroxyanthraquinone dgh Dioctyl sodium sulphosuccinate with oxyphenisatin acetate tablets dgs Diphemanil methyIsulphate tablets, long acting tablets and injection .. dgj Diphenadione dgp hydrochloride Except in any topical appIicatilln. dgq Diphenoxylate hydrochloride with atropine sulphate dgr hydrochloride long acting capsules 5 mg. and syrup .• dgz Diphtheria antitoxin 1970/18 Drug Tariff 1970 163

SCHEDULE-continued

PART II-continued Availability-continued

Code Pharmaceutical Requirement Availability Reference I

dha Dipipanone hydrochloride dhc Diprophyllin tablets dhd Dipropyline citrate dhe Disodium edetate dhg Dispersa wax dhj Disulfiram dhk Disulphamide dhm Dithranol dhn Dithranol paste, strong, B.N.F. dho Dithranol paste, weak, RN.F. dhs Dodecyl gallate .. dhv Domiphen bromide Except lozenges. dhy propionate .. Hospital Board-specialist. dhz Doxycycline hydrochloride Hospital Board-specialist. dib Dybenal ear drops dic tablets Hospital Board---specialist. dia Dyflos .. eab Echothiophate iodide Ophthalmological specialist. eaa Edrophonium chloride eag Effervescent powder, compound, B.P.C. eaj Effervescent powder, double strength, compound, RP.C. eap Electrolyte solution for oral use (e.g. Darrow's solution non-sterile; Hartmann'~ ~olution, non-sterile) According to a prescribed formula, or by title. eas Emetine and bismuth iodide eav Emetine hydrochloride eaz Emulsifying wax, B.P. eba Emulsifying ointment, B.P. ebg Eosin .. ebj Ephedrine ebm Ephedrine elixir, RP.C. .. ebp Ephedrine hydrochloride .. ebr Ephedrine with phenobarbitone tablets ehs Ephedrine nasal drops, B.P.C. ebv Ergometrine and its salts .. eca Ergot, B.P.C. ecd Ergot extract, liquid, RP. 1914 ecg Ergot extract, liquid, B.P.C. 1954- ecj Ergot, prepared, B.P.C. .. ecm Ergotamine tartrate eel Ergotamine tartrate aerosol inhaler eck Ergotamine tartrate with belladonna, caffeine and allylbarbituric acid suppositories .. ecn Ergotamine tartrate with belladonna and phenobarbitone tablets and long acting tablets ecp Ergotamine tartrate with caffeine tablets ecq Ergotamine tartrate with caffeine and cyclizine hydrochloride .. ecr Ergotamine tartrate with caffeine and meclozine hydrochloride 7* 164 Drug Tariff 1970 1970/18

SCHEDULE-continued

PART II-continued AvailabilitY-<.X)IIlItiamed

Code I Pharmaceutical Requirement Availability Reference

ect Ergotamine tartrate with caffeine citrate and diphenhydramine hydrochloride .. ecs Erythromycin and its salts and esters Antibiotic restriction. ecv Erythromycin eye ointment One tube. ecz Erythromycin eye drops .. ecy Erythromycin pessaries and supposi- tories extemporaneously prepared eda Esbach's reagent (a) Not available on a medical practitioner's supply order. (b) Not available on a bulk supply order. edb E thacrynic acid .. ede Ethambutol tablets Hospital Board-specialist. edc Ethamivan edd Ethanolamine edm Ethanolamine oleate injection edf Ether for anaesthetic purposes Only on a medical practitioner's supply order. edj E thinyloestradiol edl Ethinyloestradiol tablets with ethinyl­ oestradiol and acetate tablets for cyclic treatment Approved condition. edk Ethinyloestradiol with megestrol ace- tate .. Approved condition. edz Ethinyloestradiol with methyltestos- terone tablets .. edn Ethionamide Hospital Board-specialist. edo Ethionamide with isoniazid Hospital Board-specialist. edp eds Ethopropazine hydrochloride edt Ethosuximide edu Ethotoin edw Ethyl chloride .. Only on a medical practitioner'S supply order. eea Ethyl oleate eed Ethylenediamine hydrate eee Hospital Board--specialist. eeg Ethylmorphine hydrochloride eeh Ethynodiol diacetate with Approved condition. eei Ethylnoradrenaline hydrochloride in- jection eej Eucalyptol eem Eucalyptus oil eep Eugenol faa Fehlings solution No. I (a) Not available on a medical practitioner's supply order. (b) Not available on a bulk supply order. fad Fehlings solution No. 2 (a) Not available on a medical practitioner's supply order. (b) Not available on a bulk supply order. fac Fenfluramine hydrochloride tablets fae Fenticlor faf Ferric ammonium citrate faj Ferric ammonium citrate mixture, B.N.F. 1970/18 Drug Tariff 1970 165

SCHEDULE-continued

PART II-continued Availabiliry-continued

Code Reference I Pharmaceutical Requirement Availability

fam Ferric ammonium citrate mixture for infants, B.N.F. fap Ferric chloride solution, RP.C. fas Ferric chloride solution, strong, B.P.C. fay Ferric glycerophosphate .. faz Ferric hydroxide (colloidal iron) mix- tures and tablets fba Ferric hypophosphite fbd Ferric sulphate solution, B.P.C. fbv Ferrous fumarate fbw Ferrous fumarate with folic acid tablets fbz Ferrous gluconate fcg Ferrous phosphate with quin;ne and strychnine syrup, B.P.C. fcj Ferrous phosphate, quinine and strychnine tablets, RP.C. fcm Ferrous phosphate syrup compound, RP.C. fcn Ferrous succinate fco Ferrous succinate with succinic acid and folic acid tablets fcp Ferrous sulphate fcs Ferrous sulphate, dried fct Ferrous sulphate mixture, B.P.C. fcu Ferrous sulphate mixture for infants, B.N.F. fcv Ferrous sulphate tablets, compound, RP.C. fcy Fibrinolysin and desoxyribonuclease powder and ointment fcz Figs, syrup, compound, B.P.C. fcw Fish liver oil ointment fda Fludrocortisone and its esters Hospital Board-specialist. fdf Flumethasone pivalate with or with- out neomycin sulphate or clioqui­ nol, as skin preparations fex Flumethasone pivalate with clioqui­ nol ear drops .. fdf Fluocinolone acetonide cream exceed- ing 0.025 percent strength Dermatological specialist. fdc Fluocinolone acetonide with or with­ out neomycin sulphate or clioqui­ nol, as skin preparations fdl Fluocortolone with fluocortolone cap­ roate ointment fdq Fluocortolone with fluocortolone cap­ roate and clemizole hexachloro­ phenate ointment fcr Fluortolone caproate with fluocorto­ lone pivalate topical cream fcq Fluocortolone caproate with fluocort­ olone pivalate, cinchocaine hydro­ chloride, hexachlorophane, and clemizole undecylate ointment and suppositories .. fdb Fluopromazine hydrochloride 166 Drug Tariff 1970 1970/18

SCHEDULE-continued

PART II-continued Availability-continued

Code Reference I Pharmaceutical Requirement Availability

fdd Fluorescein sodium fde Fluorouracil sodium Hospital Board-specialist. fdg Hospital Board-specialist. ffa Fluphenazine enanthate injection fdh Fluphenazine hydrochloride fdk Fluphenazine hydrochloride long act- ting tablet!; fdi Flurandrenolone cream and oint­ ment, with or without neomycin sulphate fdj Folic acid and its sodium salt fdm Folinic acid Hospital Board-specialist. fdp Formaldehyde solution (a) Not available on a medical practitioner's supply order. (b) Not available on a bulk supply order. fds Framycetin sulphate tablets Hospital Board. fdo Framycetin sulphate for injection only Hospital Board. fdx Framycetin and its salts in prorietary eye ointments One tube. fdt Framycetin sulphate and gramicidin ointment and cream One pack. fdu Framycetin and its salts in pro­ prietary topical ointments One tube. fdy Framycetin and its salts in the form of proprietary eye/ear drops fdw Framycetin and its salts with hydro­ cortisone and it!; acetate as proprie­ tary topical preparations, except ear, nose, and throat preparations fdr Framycetin sulphate with hydro­ cortisone proprietary eye prepara­ tions .. Ophthalmological specialist. fee Framycetin sulphate with hydro­ cortisone acetate proprietary ear preparations .. fdn Framycetin sulphate with kaolin sus- pension Hospital Board. fea Frusemide fed Frusemide with reserpine tablets fdv Fuchsine (acid) with borax fdz tablets feb Fusidic acid and its salts and esters Hospital Board-specialist. gad Gallamine triethiodide gag Gamma benzene hexachloride gaj Gamma benzene hexachloride appli- cation, B.N.F. . . . . gam Gelatin gap Gelsemium tincture, B.P.C. .. gas Gelsemium and hyoscyamus mixture compound, B.P.C. .. .. gat Gentamicin sulphate cream and ointment .. .. One tube. gaw Gentamicin sulphate injection Hospital Board. gau Gentian .• .. gav Gentian infusion, compound gaz Gentian tincture, compound, B.P. 1970/18 Drug Tariff 1970 167

SCHEDULE-continued

PART II-continued A vailability-amtmueid

Code 1 Pharmaceutical Requirement Availability Reference

gba Gentian acid mixture, B.N.F. gbd Gentian alkaline mixture, B.N.F. gbg Gentian acid mixture with nux vomica, B.N.F. gbj Gentian alkaline mixture with nux vomica, B.N.F. gbm Gentian and alkali mixture with phenobarbitone, B.N.F. gbp Gentian mixture with rhubarb, B.N.F. gbv Ginger oleoresin, B.P.C. •. gbz Ginger syrup, B.P.C. gca Ginger tincture, weak, B.P. gcd Ginger tincture, strong, B.P. gce Glucagon hydrochloride injection gcg Glucose liquid .. In combination. gcj Glucose syrup In combination. gck Glucose-oxidase test strips as ap­ proved by the Director-General of Health (a) Not available on a medical practitioner's supply order. (b) Not available on a bulk supply order. gcm Glutethimide gcp Glycerin gcs Glycerin suppositories gcz Glycerophosphates syrup, com- pound, B.P.C. 1963 gda Glyceryl trinitrate solution gdd Glyceryl trinitrate tablets .. gdf tablets gde Glymidine gdg Gramicidin gdh Green Sand tartrazine solution, B.P.C. In combination. gdi Griseofulvin gIb Guaiaphenesin with theophylline cap- sules and elixir !!fa Guanethidine sulphate hem Hachimycin had Halibut-liver oil .. hae Hospital Board-specialist. haa Halopyramine hydrochloride Except in any topical application. hab Halquinol ointment and tablets hag Halquinol with benzoyl peroxide ointment hac Halquinol with tar haf Hamamelis extract, dry, B.P.C. haj Hamamelis extract, liquid, B.P.C. han Hamamelis suppositories, B.P.C. hap Hamamelis water In combination. haq Hamamelis and zinc oxide supposi- tories, B.N.F... has Heparin hav Hexachlorophane haz Hexachlorophane soap Maternity hospital only. hba Hexamethonium and its salts and esters 168 Drug Tariff 1970 1970/18

SCHEDULE-continued

PART II-continued AvailabilitY----CIOIlItilIlued

Code I Phannaceutical Requirement Availability ~eference

hbg Hexamine hbd Hexetidine vaginal application hbp Hexoestrol hbs Hexylresorcinol .. hbv Histamine acid phosphate­ hbz Homatropine hydrobromide hca Honey .. In combination. hcd Hyaluronidase .. hcg Hydergine hcp HydraIlazine hydrochloride hcq Hydrargaphen .. hcs Hydrochloric acid hcv Hydrochlorothiazide hex Hydrochlorothiazide with potassium chloride tablets hcy Hydrochlorothiazide and reserpine with potassium chloride hcz Hydrocortisone and hydrocortisone acetate including tablets and injec­ tions or a product that is not else­ where included in this Tariff Hospital Board-specialist. hdj Hydrocortisone sodium succinate intravenous inje-ction One injection only on a medical practitioner's supply order. hds Hydrocortisone and its salts and esters, alone or in combination with other pharmaceutical requirements when supplied as proprietary eye preparations approved by the Director-General of Health, or as extemporaneously prepared eye preparations .. Ophthalmological specialist. hdt Hydrocortisone and its salts and esters alone or in combination with other pharmaceutical require­ ments when supplied as proprietary ear, nose, or throat preparations approved by the Director-General of Health or as extemporaneously prepared ear, nose, or throat pre­ parations. hdu Hydrocortisone and its acetate alone or in combination with other phannaceutical requirements when extemporaneously prepared as a skin preparation and when supplied in the form of proprietary skin preparations .. hdv Hydrocortisone and its acetate alone or in combination with other phannaceutical requirements when extemporaneously prepared as a suppository hdw Hydrocortisone and its acetate for intra-articular injection hdy Hydrocortisone with lignocaine hy­ drochloride, aluminium subacetate and zinc oxide ointment and sup­ positories 1970/18 Drug Tariff 1970 169

SCHEDULE-continued

PART II-continued A uailability-oontmu'eld

Code Reference I Pharmaceutical Requirement Availability

hej Hydrocortisone with and neomycin skin preparations hdx Hydrocortisone hemisuccinate sodium tablets 2.5 mg hdz Hydroflumethiazide hea Hydroflumethiazide and potassium chloride tablets hed Hydrogen peroxide solution hee Hydroxocoba1amin injection For parenteral use not exceeding 500 mcg per ml. heg Hydroxychloroquine sulphate hem Hydroxyprogesterone caproate hey Hyoscine hydrobromide .. hez Hyoscine methobromide .. hex Hyoscine N-butylbromide injection .. hey Hyoscine N-butylbromide tablets hfa Hyoscyamus extract, dry, B.P. hfd Hyoscyamus extract, liquid, B.P. hfg Hyoscyamus tincture, B.P. iaa Ichthammol iad Ichthammol glycerin, B.P.C. iag Ichthammol ointment, B.P.C. iaj Ichthammol eye ointment, compound iam Ichthammol pessaries, B.P.C. iao Idoxuridine Ophthalmological specialist. Dermatological specialist. ian hydrochloride iap Indigo carmine .. iar Indomethacin ias Injections (hypodermic) and com­ pound hypodermic tablets of hyo­ scine, morphine, papaveretum, and atropine, and their salts iav Injections supplied in cartridge vial Limited to pharmaceutical require­ ments within this Tariff. ibb Insulin, biphasic .• iaz Insulin injection .. iba Insulin injection globin zinc iay Insulin injection, neutral .. ibd Insulin injection protamine zinc ibe Insulin isophane injection ibc Insulin, pork, soluble ibg Insulin zinc suspension ibj Insulin zinc suspension (amorphous) ibm Insulin zinc suspension (crystalline) ibl Intravenous fluids (electrolyte) Intravenous fluids. ibn Intravenous fluids (plasma substitute) Intravenous fluids. ibo Intravenous fluids (nutrient) Intravenous fluids. ibq Invert syrup, B.P.C. In combination. ibp Iodine Except in any proprietary pre­ paration. ibs Iodine ointment, non-staining, B.P.C. ibv Iodine ointment with methyl sali­ cylate, non-staining, B.P.C. ibz Iodine paint, compound, B.P.C. ica Iodine solution, aqueous, B.P. 170 Drug Tariff 1970 1970(18

SCHEDULE-continued

PART II-continued

Availabiliry-continued

Code I Pharmaceutical Requirement Reference Availability

icj Iodine solution, weak, B.P. (a) On the prescription of a medical practitioner. (b) Midwifery order (50 ml). icp Ipecacuanha, prepared, B.P. ics Ipecacuanha extract, liquid, B.P. icv Ipecacuanha tincture, B.P. ieu Ipecacuanha opiate mixture, pedia- tric, B.P.C. ida Ipecacuanha mixture for infants, B.P.C. idd Ipecacuanha and ammonia mixture for infants, B.P.C. idg Ipecacuanha and morphine mixture, B.N.F. idj Ipecacuanha and squill linctus for infants, B.N.F. idm Ipecacuanha and opium powder, B.P.C. idn Ipecacuanha and opium tablets, B.P.C. idt Iron carbohydrate complex intra­ muscular injection as approved by the Director-General of Health idv Iron phosphate, B.P.C. idu Iron polymaltose injection idz Isinglass In combination. idy Isocarboxazid iea Isoniazid Hospital Board-specialist. ieb Isoniazid with aminosalicylic acid and its salts Hospital Board-specialist. ied Isoprenaline spray, B.P.G. ieg Isoprenaline spray, compound, B.P.C. iej Isoprenaline hydrochloride iei Isoprenaline hydrochloride aerosol inhaler iek Isoprenaline hydrochloride long act­ ing tablets iel Isoprenaline hydrochloride with atro­ pine methonitrate aerosol inhaler iec Isoprenaline hydrochloride with phenylephrine bitartrate aerosol inhaler iem Isoprenaline sulphate ieq Isoprenaline sulphate aerosol inhaler ier Isoprenaline sulphate with atropine methonitrate aerosol inhaler ien Isoprenaline and its salts with atro­ pine and its salts ieo iodide liquid and tab- lets " iep Isopropyl alcohol ies Isopropyl myristate iev Isothipendyl hydrochloride Except in any topical application. iew Isothipendyl hydrochloride long act- ing tablets iez Ispaghula 1970/18 Drug Tariff 1970 171

SCHEDULE-continued

PART II-continued Availability----oontinuoo

Code Reference I Pharmaceutical Requirement Availability ~------~------kab Kanamycin sulphate Hospital Board. kaa Kaolin, colloidal kad Kaolin, and morphine, mixture, B.N.F. kag Kaolin, heavy kaj Kaolin, light kam Kaolin, mixture, B.N.F. kap Kaolin mixture for infants, B.N.F... kas Kaolin powder, compound, B.N.F. kav Kaolin, poultice, B.P. kaw Kaolin with neomycin sulphate and pectin suspension Hospital Board. laa Lachesine chloride lac Lachesine eye-drops, B.P.C. laf , B.P. laj Lactic acid irrigation, B.P.C. lam Lactic acid pessaries, B.P.C. lap Lactose In combination. las Lactose hypodermic tablets lat Lactose suppositories law Laevo-adrenaline hydrochloride buf- fered ophthalmic solution Ophthalmological specialist. lax Laevulose, B.P... In combination. laz Lanatoside C Iba Lanatoside C, desacetyl injection lbe Lard, benzoinated .. lbg Lavender oil In combination. lbj Lavender oil, spike In combination. Ibm Lead acetate lbp Lead lotion, B.P.C. lbs Lead lotion, evaporating, B.P.C. lbz Lead lotion, compound, B.N.F. lea Lead monoxide .. led Lead subacetate solution, dilute, B.P.C. leg Lead subacetate solution, strong, B.P.C. lem Lemon oil In combination. lcn Lemon spirit lcp Lemon syrup, B.P.C. lcv Leptazol lcw Leptazol injection, B.P.C. lcz Levallorphan tartrate ldd Levorphanol tartrate lde Lignocaine ldg Lignocaine hydrochloride with or without adrenaline or noradrenaline ldh Lignocaine hydrochloride and chlor- hexidine gluconate jelly .. ldi Lincomycin hydrochloride Hospital Board-specialist. ldj Linctus, simple, B.N.F. ldm Linctus, simple, for infants, B.N.F. lds Linseed oil In combination. ldv Liothyronine sodium lea Liquorice extract, B.P.C... led Liquorice extract, liquid, B.P. lef Liquorice powder, compound, B.P.C. 172 Drug Tariff 1970 1970/18

SCHEDULE-continued

PART II-continued A vailability-oontmuoo

Code I Pharmaceutical Requirement Availability Reference .--:.------;------.-- leg Lithium carbonate tablets Hospital Board-specialist. lej Liver extract (with or without added cyanocobalamin) injections Not exceeding cyanocobalamin. 500 mcg per ml. lep Lobelia tincture, ethereal, B.P.C. les Lobelia and stramonium mixture, compound, B.N.F. lev Lobeline hydrochloride lfb Lymecycline Antibiotic restriction. Ife Lynoestrenol with mestranol Approved condition. lez Lypressin spray, B.N.F. mac Macrogol derivatives maa Macrogol, hard .. mab Macrogol, liquid maf Macrogol ointment, B.P.C. maj Magenta mam Magenta paint, B.P.C. map Magnesium carbonate, heavy mas Magnesium carbonate, light mav Magnesium carbonate mixture, B.N.F. maz Magnesium carbonate mixture, aro­ matic, B.N.F... mba Magnesium carbonate powder, com­ pound, B.P.C. mbd Magnesium carbonate tablets, com- pound, B.P.C. mbe Magnesium chloride mbj Magnesium hydroxide mbk Magnesium hydroxide mixture, B.P. mbp Magnesium oxide, light mbq Magnesium stearate mbs Magnesium sulphate mbv Magnesium sulphate, dried mbz Magnesium sulphate mixture, B.N.F. mca Magnesium sulphate paste, B.P.C..• mcd Magnesium trisilicate mcg Magnesium trisilicate mixture, B.N.F. mcm Magnesium trisilicate with aluminium hydroxide gel dried tablets men Magnesium trisilicate with aluminium hydroxide gel, dried, and dried skim milk tablets mcj Magnesium trisilicate and belladonna mixture, B.N.F. mcp Magnesium trisilicate powder, com- pound, B.P.C. mes Maize oil mcv Male fern extract, B.P. mcz Male fern extract capsules mda Maleic acid . . • . mdd Malt extract, B.P.C. In combination. mdg Malt extract, liquid, B.P.C. 1954 In combination. mdj Malt extract with cod-liver oil mdm Malt extract with halibut-liver oil mdp Malt extract with vitamins mds Maltose In combination. 1970/18 Drug Tariff 1970 173

SCHEDULE-continued

PART II-continued Availability-continued

Code I Reference Pharmaceutical Requirement Availability

mdv Mandelic acid .. mdz Manganese butyrate injection meb Manganese injection, colloidal med Manganese sulphate meg Mannitol meh Mannomustine hydrochloride Hospital Board-specialist. mej Maphenide mem Maphenide solution 5 percent mes Mastic paint, compound, B.P.C. met Mebhydrolin napadisylate Except in any topical application. meu Mebhydrolin napadisylate long acting tablets mev Mecamylamine hydrochloride mez Meclozine hydrochloride .. Except in any topical application. mey Meclozine hydrochloride and pyri- doxine hydrochloride tablets mew acetate injec­ tion .. (a) Approved condition. (b) Not available on a medical practitioner's supply order. mex Medroxyprogesterone acetate tablets Approved condition. mer l\1edroxyprogesterone acetate tablets exceeding 5 mg strength Hospital Board-specialist. mfc Medroxyprogesterone acetate with I ethinyloestradiol tablets Approved condition. rnfd Medrysone eye drops Ophthalmological specialist. mfh Mefenamic acid capsules .. Hospital Board-specialist. rnfb Melphalan Hospital Board-specialist. rnfa Menadoxime mfg Menaphthone sodium bisulphite mfi Menaphthone sodium diphosphate .. rnfj Menthol rnfm Menthol and benzoin inhalation, B.P.C. rnfp Menthol and eucalyptus inhalation, B.P.C. rnfv Menthol inhalation, B.N.F. mga Mepacrine menthanesulphonate mgg Mephenesin mgj Meprobamate mgh Meprobamate long acting capsules mgm Mepyramine maleate Except in any topical application. mgt Mercaptomerin sodium mgv Mercaptopurine .. Hospital Board-specialist. mgz Mercuramide with theophylline mha Mercuric chloride mhd Mercuric iodide .. mia Mercuric nitrate ointment, dilute, B.P.C.1959 mhg Mercuric nitrate ointment, strong, B.P.C.1959 mhj Mercuric oxide eye ointment, B.P.C. mhm Mercuric oxide, yellow mhp Mercuric oxycyanide mhq Mercuric potassium iodide mhs Mercurochrome .. mid Mercury, ammoniated 174 Drug Tariff 1970 1970/18

SCHEDULE-continued

PART II-continued Availabiliry-continued

Code I Pharmaceutical Requirement Availability Reference

mig Mercury, ammoniated, and coal tar ointment, B.P.C. mij Mercury, ammoniated, and coal tar with salicylic acid ointment, B.N.F. mja Mercury with chalk, RP.C. 1954 .. mjc Mersalyl and theophylline supposi- tories mjd Mersalyl acid mjh Hospital Board-specialist. mji Mestranol tablets with mestranol and acetate tablets for cyclic treatment Approved condition. mjl Metaraminol tartrate mjn Metformin hydrochloride .. mjm chloride mjp Methadone hydrochloride mjs Methadone linctus, B.P.C. mjr Methallenoestril .. Hospital Board. mjt Methandienone .. Hospital Board-specialist. mIv Hospital Board-specialist. mpa Methaqualone and diphenhydramine hydrochloride tablets mjy Methaqualone hydrochloride tablets mkb Metharbital mkc hydrochloride Except in any topical application. mkd Methenamine mandelate .. mke Methicillin sodium Hospital Board-specialist. mpb Methionine tablets mkh Methohexitone sodium injection Medical practitioner's supply order of a psychiatric specialist. mkg Methoin mkm Methotrexate Hospital Board-specialist. mlm Methotrimeprazine and its salts and esters mkp Methoxamine hydrochloride mks Methsuximide .. mkt Methyclothiazide mkv Methyl hydroxybenzoate .. mkz Methyl salicylate mIa Methyl salicylate liniment, RP.C. mId Methyl salicylate ointment, B.P.C. mlg Methyl salicylate ointment, com- pound, RP.C. mlj Methyl salicylate ointment, dilute, B.N.F. mIm Methylamphetamine hydrochloride mIn Methylamphetamine hydrochloride injection Only on a medical practitioner's supply order. mma Methylcellulose .. In combination. mmb Methylcellulose sterile eye drops mmc Methyldopa mme Methyldopa with hydrochlorothia­ zide tablets mmf Methyldopa with hydrochlorothia­ zide and potassium chloride tablets mmd Methylergometrine maleate 1970/18 Drug Tariff 1970 175

SCHEDULE-continued

PART II-continued Availability--oontinuoo

ReferenceCode I Pharmaceutical Requirement Availability

mmg Methylene blue .. mmp Methylphenidate hydrochloride mmq Methylphenidate hydrochloride injec- tion •. Only on a medical practitioner's supply order. mmv Methylprednisolone and its salts and esters Hospital Board-specialist. mmz mna Methylthiouracil mmx Methyprylone mmy Methysergide dimaleate Hospital Board-specialist. mnc " mne Metyrapone capsules Hospital Board-specialist. mmu Mexenone cream Dermatological specialist. mnb Mitomycins Hospital Board-specialist. mnd Monostearin, self-emulsifying, B.P.C. mng Morphine with atropine (hypoder- mic) mnj Morphine and atropine injection mnm Morphine and hyoscine injection, B.N.F. mnp Morphine hydrochloride mns Morphine mucate mnv Morphine sulphate moa Mouth-wash solution tablets, B.P.C. moc Mucilaginous laxatives dry As approved by the Director­ General of Health. mod Mustine its salts and derivatives Hospital Board-specialist. moj Myrrh tincture, B.P.C. nab Nalidixic acid naa Nalorphine hydrobromide nac decanoate injection Hospital Board-specialist. nad Nandrolone phenylpropionate injec- tion .. Hospital Board-specialist. nag Naphazoline hydrochloride naj Naphazoline nitrate . . . . nap Naphazoline nasal-drops, B.P.C. 1954 nar Natamycin Except suspension exceeding 1 per­ cent strength. nat Nealbarbitone tablets naz Neomycin for oral use . . . . Hospital Board. nba Neomycin and its salts for topical use nbc Neomycin and its salts as eye drops nbd Neomycin and its salts as eye ointment nbj Neomycin and gramicidin topical ointment One tube. nbk Neomycin and gramicidin eye oint- ment One tube. nbm Neostigmine bromide nbp Neostigmine methylsulphate nbq Nialamide tablets Hospital Board-specialist. nbr Niclosamide tablets nbs nbv Nicotinic acid nbz Nicotinyl alcohol, and its esters nby Nicotinyl alcohol long acting tablets nc:a Nikethamide 176 Drug Tariff 1970 1970/18

SCHEDULE-continued

PART II-continued Availability-oontinuoo

Code I Pharmaceutical Requirement Reference Availability

nea Nitrazepam capsules and tablets llcd Nitric acid nce Nitrofurantoin .. ncg Nitrofurazone nch Nitrogen mustard-N-oxide Hospital Board-specialist. nci Nitrous oxide Anaesthetic gases. llcm Noradrenaline acid tartrate llCP N orethandrolone Hospital Board-specialist. ncs Approved condition. ncq Norethisterone with mestranol tablets Approved condition. nco Norethisterone acetate Approved condition. nct Norethisterone acetate and ethinyl- oestradiol Approved condition. ncu Norethynodrel and mestranol Approved condition. ncn N orgestrel with ethinyloestradiol Approved condition. ncr hydrochloride ncx Noscapine linctus, B.P.C. ncv Novobiocin and its salts .. Hospital Board. ncz Nutmeg oil ndd Nux vomica acid mixture, B.P.C. ndg Nux vomica alkaline mixture, B.N.F. ndj Nux vomica elixir, B.N.F. ndp Nux vomica extract, liquid, B.P. nds Nux vomica tincture, B.P. ndv Except sterile powder. oab Octyl gallate oaa Octyl nitrite oad Oestradiol Except in any topical application. oag Oestradiol benzoate Except in any topical application. oai Oestradiol benzoate with oestradiol phenylpropionate, pro­ pionate, testosterone phenylpropio­ na te, and testosterone isocaproa te injection oah Oestradiol benzoate with oestradiol valerate, norethisterone acetate and testosterone oenanthate for injec­ tion .. oaj Oestrone Except in any topical application. oak Oestrone pessaries and suppositories oao Oily cream, B.P. oav Oleic acid oaz Olive oil (a) On the prescription of a med­ ical practitioner. (b) Midwifery order (100 ml). (c) Maternity hospital. oba Opiate squill linctus, B.P.C. obd Opiate squill linctus for infants, B.P.C. obf Opipramol obg Opium, B.P.C. .. obj Opium camphorated mixture, com- pound, B.N.F. obm Opium powdered, B.P.C. obp Opium tincture, B.P. obs Opium tincture, camphorated, B.P. obz Orange oil, terpeneless, B.P.C. In combination. oca Orange peel infusion 1970/18 Drug Tariff 1970 177

SCHEDULE-continued

PART II-continued

Availability-

Code I Availability Reference Pharmaceutical Requirement

ocd Orange spirit, compound, B.P.C. oce Orange syrup ocg Orange tincture .. och Orciprenaline sulphate oci citrate tablets and in- jection ocj Orphenadrine hydrochloride ocn Oxazepam tablets ocm Oxyprenolol hydrochloride Hospital Board-specialist. ocq Oxybuprocaine hydrochloride Medical practitioner's supply order. ocr Oxygen Anaesthetic gases. ocs Oxymel, B.P.C... ocv Oxymel of squill, B.P.C. ocy Hospital Board-specialist. ocu Oxymetazoline hydrochloride nasal preparations .. oco .. Hospital Board-specialist. ocw Oxyphenbutazone ocx hydrochloride tablets odd Oxyphenistatin acetate suppositories odb Oxyphenistatin acetate with dan­ thron and dioctyl sodium sulpho­ succinate tablets ocz .. oda and derivatives Antibiotic restriction. odk Oxytetracycline suppositories, extem- poraneously prepared .. ode Oxytetracycline hydrochloride topi­ cal preparations with or without other pharmaceutical requirements, when extemporaneously prepared odg Oxytetracycline with polymyxin B sulphate proprietary eye drops odj Oxytetracycline with lignocaine in­ jection, B.N.F. odm Oxytocin odn Oxytocin with ergometrine maleate injection paa Pancreatin, all strengths .. pac Pancreatin powder, strong, B.N.F. paf Pancreatin tablets, strong, B.N.F. .. pab Pancreatin proprietary prepara- tions as approved by the Director­ General of Health Hospital Board-specialist. pad Papaveretum pae Papaveretum and hyoscine hydro- bromide injection pag hydrochloride pah Paracetamol pai Paracetamol elixir for infants, B.P.C. pak Paracetamol with codeine phosphate tablets pas Paraldehyde pav Paraldehyde draught, B.P.C. paz Paraldehyde enema, B.N.F. pba Paraldehyde injections, B.N.F. 178 Drug Tariff 1970 1970/18

SCHEDULE-continued

PART II-continued Availabiliry-continued

Code Phannaceutical Requirement Availability Reference I

pbe Para-aminobenzoic acid .• pbg Para-aminosalicylic acid and its salts and derivatives Hospital Board-specialist. pbm Paraffin, hard pbp Paraffin, liquid .. pbs Paraffin, liquid emulsion, B.P.C. pbv Paraffin emulsion with cascara, B.N.F. pbz Paraffin liquid and magnesium hydroxide emulsion, B.N.F. pca Paraffin liquid and phenolphthalein emulsion, B.N.F. per; Paraffin, white, soft pCJ Paraffin, yellow, soft pcm Paraffin ointment, B.P. pcp Paramethadione .• pes Para-methylsulphonyl benzylamine propionate eye drops pcy Paromomycin sulphate Hospital Board. pcv Paroxyproprione Hospital Board-speciaIist. pda Peanut oil (a) On the prescription of a medical practitioner. (b) Midwifery order (100 ml). pdd Pecazine acetate Pecazine hydrochloride ~f Pempidine tartrate pdp Penicillins with streptomycins for injection, mixed pdz Penicillamine hydrochloride Hospital Board. pef Pentaerythritol tetranitrate, diluted peg Pentaerythritol tetranitrate long act- ing tablets pep Pentobarbitone sodium pes Pentolinium tartrate pet Pentolinium tartrate and ephedrine and its salts pev Peppennint oil .• In combination. pfa Peppennint spirit pfb Peppermint water In combination. pfc Pericyazine pfg Perphenazine pfh Perphenazine long acting tablets pfj Peru balsam pfm hydrochloride pfp Pethidine and atropine injection and tablets pfs Pethidine and hyoscine injection and tablets .. .. •. pfv Pethidine and levallorphan injection and tablets . . . . • . pfw Petrolatum red with titanium coated mica ointment Dennatological specialist. pfz Phenacetin pga Phenacetin and caffeine tablets, B.P.C. pgc Phenazocine hydrobromide injection pgd Phenazone •. •. •• 1970/18 Drug Tariff 1970 179

SCHEDULE-continued

PART II-continued Availability----cootinued

Code Pharmaceutical Requirement Availability Reference I

pge Phenelzine sulphate pgf Phenformin hydrochloride pgh Phenformin hydrochloride long acting capsules pgg hydrochloride pgj tartrate Except in any topical application. pgm Phenindione pgn and its salts and esters Except in any topical application. pgo Pheniramine maleate long acting tablets pgp Phenobarbitone pgs Phenobarbitone and theobromine tablets, B.P.C. pgv Phenobarbitone elixir, B.P.C. pgz Phenobarbitone sodium .. pha Phenol phd Phenol and hydrogen peroxide gargle, N.Z.F. 1953 .. phj Phenol ear drops, B.P.C. phi Phenol gargle, B.P.C. phm Phenol glycerin .. php Phenol, liquefied phs Phenolphthalein phv Phenolphthalein pills, compound phz Phenolsulphonphthalein .. pia Phenoxybenzamine capsules, B.P. pid Phenoxyethanol pij Phenoxymethylpenicillin and its salts Penicillin restriction. pip Phenoxymethylpenicillin capsules .. Penicillin restriction. pir Phenoxymethylpenicillin hydrabam- ine .. Penicillin restriction piv Phenoxymethylpenicillin tablets Penicillin restriction. piw Phenprocoumon .. piz Phensuximide pjd Phentolamine mesylate pjq Phenylaminosalicylate Hospital Board-specialist. pjg Phenylbutazone injections supposi- tories and tablets pjj Phenylephrine hydrochloride Except in any preparation for oral administration. pjk Phenylephrine hydrochloride with hydrochloride nasal preparations .. pjo Phenylmercuric acetate pjp Phenylmercuric nitrate pjt pjv Phenytoin sodium Except in any proprietary suspension containing 30 mg per 4 ml. pjw Phenytoin sodium long acting cap­ sules pjz Phenytoin sodium with phenobarbi- tone sodium tablets • . . . pka Pholcodine pkd Pholcodine linctus, B.P.C. pke Pholcodine linctus, strong, B.P.C. pkj Pholcodine tartrate pkm Phosphoric acid 180 Drug Tariff 1970 1970/18

SCHEDULE-continued

PART II-continued Availabiliry-con tinued

Code I Pharmaceutical Requirement Availability Reference

pkz Phthalylsulphathiazole pkr Physostigmine pks Physostigmine salicylate pkt Physostigmine sulphate pld Phytomenadione plh hydrochloride plj Pilocarpine nitrate plm Piperazine and its salts plv Piperazine citrate elixir, B.N F. plz Piperazine phosphate and senna ex- tract, standardised pmk Pituitary (posterior lobe) injection, B.P.C.1959 pml Pituitary (posterior lobe) insufflation pmm Pituitary (posterior lobe) powdered pmv Podophyllum resin pmz Podophyllin compound paint, B.N.F. pna Polawax pmx methylsulphate pmu Poloxalkol pediatric drops pmy .. Hospital Board-specialist. pnd Polymyxin B sulphate For injection only. pnc Polymyxin B sulphate proprietary ear solution pnb Polymyxin B sulphate proprietary eye drops pni Polymyxin B sulphate with neomycin sulphate proprietary eye drops pnf Polymyxin B sulphate with neomycin sulphate as proprietary lotions and powders One pack. pne Polymyxin B sulphate and neomycin sulphate with gramicidin propriet­ ary ophthalmic solution .. pnl Polymyxin B sulphate with neomycin sulphate and gramicidin propriet­ ary skin cream One tube. pnh Polymyxin B sulphate with neomycin sulphate and hydrocortisone pro­ prietary ear drops pnq Polymyxin B sulphate with zinc baci- tracin proprietary dusting powder pwb Polynoxylin gel .. pnk Poly thiazide pob Polyvinyl alcohol eye drops Ophthalmological specialist. poc Potassium acid phosphate png Potassium acid tartrate pnj Potassium bicarbonate pnm Potassium bromide pog Potassium bromide and belladonna mixture for infants, B.N.F. poj Potassium chlorate Except lozenges. pom Potassium chlorate and phenol gargle, B.P.C. poq Potassium chloride pos Potassium chloride injection, B.N.F. pou Potassium chloride long acting tablets 1970/18 Drug Tariff 1970 181

SCHEDULE-continued

PART II-continued

Availability~OIlJtinueid

Pharmaceutical Requirement Availability ReferenceCode "

pot Potassium chloride and dextrose in- jection, B.N.F. pov Potassium citrate poz Potassium citrate mixture, B.N.F. ppa Potassium citrate and belladonna mixture for infants, B.N.F. ppd Potassium citrate and hyoscyamus mixture, B.P.C. ppg Potassium citrate mixture for infants, RN.F. pph Potassium gluconate ppm Potassium hydroxide ppp Potassium hydroxyquinoline sulphate ppv Potassium iodide ppz Potassium iodide ammoniated mix- ture, B.N.F. pqa Potassium nitrate pqb Potassium para-aminobenzoate Hospital Board-·specialist. pqd Potassium perchlorate pqj Potassium permanganate .. pqk Potassium tablets, effervescent, B.P.C. pqm Prednisolone and its salts and esters Hospital Board-specialist. pqo Prednisolone and its acetate as tablets pqp Prednisolone and its salts and esters, alone or in combination with other pharmaceutical requirements as proprietary eye preparations ap­ proved by the Director-General of Health Ophthalmological specialist. pqq Prednisolone and its salts and esters, alone or in combination with other pharmaceutical requirements as proprietary ear, nose, or throat preparations approved by the Director-General of Health pqr Prednisolone with neomycin hydro­ chloride and Surfen eye ointment Ophthalmological specialist. pqs Prednisolone acetate with neomycin sulphate and polymyxin B sulphate proprietary ear drops prb Prednisolone acetate with neomycin sulphate and polymyxin B sulphate proprietary eye drops .. Ophthalmological specialist. pqn Prednisolone sodium phosphate for use as an enema pql Prednisolone sodium phosphate sup­ positories pqi Prednisolone sodium phosphate with neomycin sulphate, phenylephrine hydrochloride and phenylpropano­ lamine hydrochloride nasal spray pqw Prednisolone pivalate for intra- articular injection Hospital Board-specialist. prc Prednisolone stearoylglycolate tablets pqz Prednisone and its acetate Hospital Board-specialist. pqy Prednisone and its acetate as tablets pra Primaquine phosphate 182 Drug Tariff 1970 1970/18

SCHEDULE-continued

PART II-continued Availabiliry-continued

Code Pharmaceutical Requirement Reference I Availability

prd Primidone prq Probenecid prj Procainamide hydrochloride prp Procaine hydrochloride pro Procaine hydrochloride with adrena- line injection .. prs Procaine penicillin prw Procarbazine hydrochloride Hospital Board-specialist. prz Prochlorperazine, its salts and esters psd Procyc1idine hydrochloride psg Proflavine hemisulphate .. psj Proflavine solution-tablets, B.N.F. psm psp Proguanil hydrochloride tablets psv hydrochloride .. pta hydrochloride Except in any topical application. ptb Promethazine hydrochloride and pethidine hydrochloride injection ptc Promethazine hydrochloride, pethi­ dine hydrochloride and atropine sulphate injection pte Promethazine hydrochloride, pethi­ dine hydrochloride and hyoscine hydrobromide injection ptd Promethazine theoc1ate ptg Promulsin ptj Promulsin wax .. ptm Propamidine isethionate ophthalmic solution pto Propanidid Only on a medical practitioner's supply order. ptn I, 2-Propanediol diacetate with acetic acid and benzethonium chloride ear drops ptp ptr Propranolol hydrochloride Hospital Board--specialist. ptv Propyl gallate ptz Propyl hydroxybenzoate .. pua Propylene glycol puj Propylthiouracil pum Protamine sulphate injection pun Prothionamide tablets Hospital Board--specialist. put hydrochloride tablets puu Proxymetacaine hydrochloride eye- drops Only on a medical practitioner's supply order. puo Pseudoephedrine hydrochloride tablets pus Psyllium puv Pumilio pine oil pvd Pyridostigmine bromide pvg Pyridoxine hydrochloride pvj Pyrimethamine .. pvm Pyroxylin qaa Quassia qaj Quillaia extract, liquid, B.P.C. qam Quillaia tincture, B.P.C... 1970/18 Drug Tariff 1970 183

SCHEDULE-continued

PART II-continued Availability-oontmued

Code I Reference Pharmaceutical Requirement Availability

qap Quinalbarbitone sodium .. qar capsules Hospital Board-specialist. qaq bisulphate long acting tablets Hospital Board-specialist. qas Quinidine sulphate qba Quinine bisulphate qbd Quinine dihydrochloride qbg Quinine hydrochloride qbm Quinine sulphate raa Radiographic preparatory substances Bulk supply order of a private hos­ pital, or medical practitioner's supply order of a radiological specialist, or other practitioner's prescription when necessary. rad Rapeseed oil rag Raspberry juice concentrated, B.P.C. In combination. raf Raspberry syrup, B.P.C... In combination. raj Rauwolfia (total alkaloids) ram Rauwolfia (alkaloids fraction) ran Rauwolfia (whole root), standardised tablets rao Rauwolfia (whole root), standardised and hydroflumethiazide with po­ tassium chloride tablets rap Reserpine ras Resorcinol rav Resorcinol ointment, compound, B.P.C. raz Resorcinol and sulphur paste, B.P.C. rbd Rhubarb and soda ammoniated, mix­ ture, B.N.F. rbj Rhubarb mixture, compound, B.N.F. rbm Rhubarb mixture, compound, for infants, B.N.F. rbs Rhubarb powder, compound, B.P.C. rbz Rhubarb tincture, compound, B.P. rca Riboflavine rcb Rifampicin for the treatment of tuber­ culosis Hospital Board-specialist. rcc Rolitetracycline and its nitrate for in- jection Antibiotic restriction. rce Rose water In combination. rcd Rosemary oil In combination. rcg Rothera's reagent (a) Not available on a medical practitioner's supply order. (b) Not available on a bulk supply order. saa Saccharin and saccharin elixir In combination. sam aerosol inhaler sad Salicylic acid saf Salicylic acid and sulphur ointment, B.P.C. saj Salicylic acid collodion, B.P.C. sar Salicylic acid lotion, B.P.C. sas Salicylic acid ointment, B.P. sat Salicylic acid and dithranol paste, strong, B.N.F. 184 Drug Tariff 1970 1970/18

SCHEDULE-continued

PART II-continued A vailability-collJtinued

Code Pharmaceutical Requirement Availability Reference I

sau Salicylic acid and dithranol paste, weak, B.N.F. sav Salicylic acid and mercuric chloride lotion, B.P.C. saz Salicylic acid and sulphur cream, B.P.C. sba Saline mixture, B.P.C. sbd Santonin sbj Scarlet red sbm Senega infusion .. sbp Senega extract, liquid, B.P.C. sbs Senega tincture, B.P.C. sbv Senna fruit sca Senna leaf scg Senna extract, liquid, B.P.C. sch Senna extract, standardised scm Sesame oil scp Shellac In combination. scs Silver nitrate scv Silver nitrate, mitigated, B.P.C. scz Silver nitrate, toughened, B.P. sda Silver protein, B.P.C. sdd Silver protein, mild, B.P.C. sdg Silver picrate sdj Silver picrate compound insufflation powder sdk Simple eye ointment, B.N.F. sdi Simple ointment, B.P. sdo Simple syrup In combination. sdm Soap, curd In combination. sdn Soap, soft In combination. sdp Soap, solution, ethereal sds Soap, hard In combination. sdv Soap liniment, B.P.C. sdw Soap solution, compound, N.Z.F. 1953 .. sdz Soap spirit, industrial In combination. sdy Soap spirit, potash, industrial In combination. sea Sodium acetate sed Sodium acid citrate seg Sodium acid phosphate sej Sodium alginate sep Sodium aminosalicylate and isoniazid cachets, B.N.F. Hospital Board-specialist. seq Sodium aminosalicylate and isonia- zide granules, B.N.F. Hospital Board-specialist. ses Sodium antimonylgluconate sev Sodium aurothiomalate sez Sodium benzoate sfd Sodium bicarbonate sfe Sodium bicarbonate ear drops, B.N.F. sfg Sodium bicarbonate mixture for in- fants, B.N.F. .. sfj Sodium bicarbonate tablets, com­ pound,B.P. sfm Sodium bromide sfp Sodium calciumedetate 1970/18 Drug Tariff 1970 185

SCHEDULE-continued

PART II-continued A vailability--rontinued

Code I Reference Pharmaceutical Requirement Availability

sfs Sodium carbonate sfv Sodium carbonate, anhydrous sfw Sodium carboxymethycellulose In combination. sfx Sodium carboxymethycellulose with pectin and gelatin paste and powder sfz Sodium chloride sgd Sodium chloride and dextrose injec­ tion, B.P. Intravenous fluids. sgg Sodium chloride mixture, compound, B.N.F. sgh Sodium chloride mouth wash, com- pound, B.N.F. sgj Sodium citrate .. sgm Sodium citrate mixture, B.N.F. sgl Sodium citrate with sodium lauryl sulphoacetate and sorbitol enema sgo Sodium cyclamate In combination. sgn Sodium fluoride sgv Sodium hydroxide sha Sodium iodide .. shd Sodium lactate injection, compound, B.P. Intravenous fluids. shg Sodium lactate injection, B.N.F. Intravenous fluids. shj Sodium lauryl sulphate shm Sodium metabisulphite shp Sodium nitrate .. shs Sodium nitroprusside (a) Not available on a medical practitioner's supply order. (b) Not available on a bulk supply order. sht Sodium nitroprusside with amino­ acetic acid diagnostic tablets (a) Not available on a medical practitioner's supply order. (b) Not available on a bulk supply order. shv Sodium perborate shz Sodium phosphate sic Sodium polyhydroxyaluminium monocarbonate hexitol complex tablets sid Sodium polymetaphosphate sie Sodium polystyrene sulphonate Hospital Board-specialist. sig Sodium potassium tartrate sij Sodium salicylate sim Sodium salicylate mixture, B.N.F. sip Sodium ~alicylate mixture, strong, B.N.F. sis Sodium stibogluconate siv Sodium sulphate siz Sodium sulphate, anhydrous sja Sodium sulphite sjd Sodium tauroglycocholate !!jg Sodium thiosulphate sjl Solution for eye drops, B.P.C. sjj Sorbide nitrate .• sjm Sorbitan derivatives sjn Sorbitol solution In combination. 186 Drug Tariff 1970 1970/18

SCHEDULE-continued

PART II-continued Availability-continued

Re7e~:ce I Pharmaceutical Requirement Availability

sjp Soyabean oil (a) On the prescription of a medical practi tioner. (b) Midwifery order (100 ml). sjv Spearmint oil In combination. sjz Spermaceti sky Spiramycin Antibiotic restriction. ska Spirit ear drops, B.N.F. skd Spirit, methylated, industrial (Methy- lated spirit W.P.) (M.S.W.P.) (a) In combination with other drugs when prescribed by a doctor for an individual patient. (b) In small quantities, e.g. 100 to 300 ml, when prescribed by a doctor for an individual patient. (c) Not available on a medical practitioner's supply order. (d) Not available on a bulk supply order for a licensed hospital with the exception of an order representing a collation of doctors' prescriptions for individual patients. skj Spirit methylated, denatured(S.V.M. coloured) Available only on a bulk supply order for a private hospital. ske Spirit methylated, industrial (acetone free) B.P.C. (a) In combination with other drugs when prescribed by a doctor for an individual patient. (b) In small quantities, e.g., 100 to 300 ml, when prescribed by a doctor for an individual patient. (c) Not available on a medical practitioner's supply order. (d) Not available on a bulk supply order for a licensed hospital with the exception of an order representing a collation of doctor's prescriptions for individual patients. skm Spirit, surgical, B.P.C. (a) In small quantities, e.g., 100 to 300 ml, when prescribed by a doctor for an individual patient. (b) Not available on a bulk supply order for a licensed hospital. (c) Not available on a medical practitioner's supply order. (d) Not available in combination with other pharmaceutical requirements. skp Spirit, cologne, industrial .. In combination. sks Spirit, bay, compound, industrial In combination. skw .. . . Hospital Board-specialist. skz Squill extract, liquid, B.P.C. 1970/18 Drug Tariff 1970 187

SCHEDULE-continued

PART II-continued

A vailability-oontmuro

Code Reference I Pharmaceutical Requirement Availability

sky Squill opiate linctus, pediatric, B.N.F. sib Squill syrup, B.P.C. sla Squill tincture, B.P.C. sld Squill, vinegar of, B.P.C... slf Stanolone Hospital Board--specialist. slg Starch .. slm Stearic acid sip Sterculia sls Stibophen slv Stilboestrol slz Stilboestrol diphosphate Hospital Board-specialist. sma Stilboestrol dipropionate smd Stilboestrol pessaries, B.P.C. smg Stomach tissue, desiccated smj Storax, prepared, B.P.C. smm Stramonium and potassium iodide mixture, B.N.F. sms Stramonium extract, liquid, B.P. smv Stramonium tincture, B.P. sng Streptokinase and streptodornase Except oral tablets. snh Streptomycin mixture for infants, B.P. snm Streptomycin sulphate Except in any skin preparation. snd Streptonicozid .. Hospital Board--specialist. snv Strychnine hydrochloride .. soe Succinylsulphathiazole sof Succinylsulphathiazole mixture for infants, B.P.C. soj Sugar .. In combination. sop Sulkowich's reagent (a) Not available on a medical practitioner's supply order. (b) Not available on a bulk supply order. sov Sulphacetamide sodium .. sow Sulphacetamide sodium eye ointment Not exceeding 10 percent strength. soz Sulphadiazine spa Sulphadiazine sodium spd Sulphadimethoxine spg Sulphadimidine .. spm Sulphadimidine mixture for infants, B.N.F. spp Sulphadimidine sodium .. sps Sulphafurazole and derivatives spv Sulphaguanidine sqd Sulphamethizole sqe Sulphamethoxazole sqf Sulphamethoxydiazine syrup and tablets sqg Sulphamethoxypyridazine and de- rivatives sqp Sulphanilamide .. sqs Sulphaphenazole sqv Sulphapyridine sqz Sulphapyridine sodium srb Sulphasalazine suppositories and tablets srd Sulphathiazole .. sre Sulphinpyrazone 188 Drug Tariff 1970 1970/18

SCHEDULE-continued

PART II-continued Availability-continued

Code I Availability Reference Pharmaceutical Requirement

srg Sulphonamides, dual, mixture srj Sulphonamides, dual, tablets As approved by the Director­ srm Sulphonamides, triple, mixture General of Health. srp Sulphonamides, triple, tablets } SIT Sulphur lotion, B.P.C. srs Sulphur lotion, compound, B.N.F. srv Sulphur, precipitated srz Sulphur, sublimed srt Sulphur with phenol and titanium dioxide cream ssa Sulphurated potash ssg Sulphuric acid, dilute, B.P.C. ssh Sulthiame ssj Suppositories, extemporaneously pre- Limited to pharmaceutical require­ pared ments within this Tariff. sss Suxamethonium bromide ssv Suxamethonium chloride ssz Suxethonium bromide sta Synkamine taa Talc, purified tab Talc dusting powder, B.P.C. tad Tannic acid tag Tannic acid glycerin, B.P.C. taj Tar tarn Tar, coal tap Tar, coal, prepared, B.P.C. tav Tar, coal, solution taz Tartaric acid tba Tartrazine solution, compound, B.P.C. tbg Terpin hydrate .. tbj Terpineol tbm Testosterone and its esters Except in any topical application. tbs Testosterone, mixed esters, for in- jection tbv Except in any topical application. tbz Tetanus antitoxin tby Tetrabenazine .. tea Tetrachloroethylene tfc Tetracosactrin .. Hospi tal Board-specialist. tci Tetracosactrin, long acting Hospital Board-specialist. tch Tetracycline and its salts and esters Antibiotic restriction. te! Tetracycline eye drops .. tcn Tetracycline eye ointment .. One tube. tcp Tetracycline suppositories, extem- poraneously prepared .. tco Tetracycline hydrochloride topical preparations with or without other pharmaceutical requirements when extemporaneously prepared tcr Tetracycline and glucosamine .. Antibiotic restriction. tct Tetracycline and nystatin capsules .. Antibiotic restriction. tcv Tetracycline and procaine injection .. Antibiotic restriction. tcq Tetracycline hydrochloride and am- photericin-B .. . • Antibiotic restriction. tda Tetrahydrozoline hydrochloride nasal preparations .. 1970/18 Drug Tariff 1970 189

SCHEDULE-continued

PART !I-continued A vailability---oontilI1ued

Code I Reference Pharmaceutical Requirement Availability

tdp Theobroma oil tds Theobromine tdv Theophylline tdw Thiambutosine Hospital Board. tdj Thiamine hydrochloride Except tablets exceeding 50 mg each. tdm Thiamine tablets compound, B.P.C. tej Thiamine tablets compound, strong, B.P.C. tdx Thiethylperazine maleate .. tdy Thiocarlide Hospital Board--specialist. tea Thiomersal teg Thiopentone sodium injection Only on a medical practitioner's supply order. teh hydrochloride tablets tei Thioproperazine mesylate .. Hospital Board--specialist. tek hydrochloride tel Thoridazine hydrochloride long acting tablets .. thj Thiotepa Hospital Board--specialist. tem Thymol tep Thymol glycerin, compound, B.P.C. tcv Thyroid tez Thyroid (fresh gland) tablets tfa Thyroxine sodium tfb Tiemonium iodide injection and tablets tfd Titanium dioxide tfg Titanium dioxide paste, B.N.F. tfh Tolazamide tablets tfj Tolazoline hydrochloride .. tfm Tolbutamide tfn Tolnaftate solution tfs Tolu linctus for infants, compound, B.N.F. tfv Tolu solution, B.P.C. tfw Tolu syrup, B.P.C. tga Tragacanth In combination. tdg Tragacanth, powder, compound, B.P. tgg Tragacanth mucilage, B.P. tgh sulphate Hospital Board-specialist. tgf Tretamine Hospital Board--specialist. tgc Triacetyloleandomycin Antibiotic restriction. tgj Triamcinolone and its salts and esters as injections or tablets Hospital Board--specialist. tgi eye oint­ ment Ophthalmological specialist. tgs Triamcinolone acetonide for intra­ articular or intradermal injection tgo Triamcinolone acetonide with neo­ mycin sulphate and gramicidin eye ointment .. Ophthalmological specialist. tgk Triamcinolone acetonide with or without neomycin sulphate or halquinol as proprietary skin preparations .. tgt Triamcinolone acetonide with nystat­ in, neomycin sulphate and grami­ cidin proprietary skin preparations 190 Drug Tariff 1970 1970/18

SCHEDULE-continued

PART II-continued Availabiliry-continued

Code Pharmaceutical Requirement Availability Reference I

tgu Triamterene tgq Triaziquone Hospital Board-specialist. tgl Trichlormethiazide tgn Trichlormethiazide and reserpine with potassium chloride tablets tgm Trichloroacetic acid tgp Trichloroethylene (a) Not exceeding 25 ml. (b) Not available on a medical practitioner's supply order. (c) Not available on a bulk supply order. the Trichloroethylene for anaesthetic purposes Only on a medical practitioner's supply order. tgw Trichloroethylene vitrellae tgr Triclofos sodium syrup and tablets tgv Tricyclamol and salts tha Triethanolamine thl Trifluoperazine hydrochloride injec­ tion, tablets, concentrate, long act­ ing capsules and syrup forte thm Trifluoperazine hydrochloride long acting capsules thn Trimeprazine and its salts and esters thp Trimetaphan camsylate .. tho Trimethoprim with sulphamethoxa- zole .. Hospital Board-specialist. thq and its salts and esters as injection and tablets ths Trimustine hydrochloride .. Hospital Board-specialist. thx Triple syrup, RP.C. 1949 tia hydrochloride Except in any topical application. tib Triprolidine hydrochloride long act- ing tablets tiv Trisodium edetate tid Trisulphonamide mixture for infants, B.N.F.1960 tig Troxidone tij Trypan blue tim Tryparsamide tir Trypsin Except oral tablets. tis Tuaminoheptane sulphate tip Tubocurarine chloride tiz Turpentine liniment, B.P. tja Turpentine oil, B.P.C. uaa Undecenoic acid uad Urea vam Vanillin In combination. vap Vasopressin and its salts and esters as an injection vau Vinblastine sulphate Hospital Board-specialist. vat Vincristine sulphate Hospital Board-specialist. vav Viomycin and its salts Hospital Board-specialist. vaw Viprynium embonate suspension and tablets vaz Vitamin A vba Vitamin A solution, concentrated, B.P.C. 1970/18 Drug Tariff 1970 191

SCHEDULE-continued

PART !I-continued Availability-continued

Code Reference I Pharmaceutical Requirement Availability

vbd Vitamin A acetate tablets vbg Vitamin D solution concentrated, B.P.C. vbj Vitamin A and D capsules, B.P.C. vbm Vitamin A and D solution containing 25,000 i.u. A and 2,500 i.u. Din I gram vbp Vitamin A and D solution, concen­ trated, B.P.C. vbr Vitamin A and D with ascorbic acid powder vbt Vitamin B complex injection as approved by the Director-General of Health Only on the bulk supply order of a licensed hospital. vbv Vitamins capsules, B.P.C. vbz Vitamins tablets (B.P.C. capsule strength) waa Warfarin sodium wad "Vater, purified waf Water for injection wam White liniment, B.P.C. wap Wild cherry syrup, B.P.C. was Wool alcohols, B.P.C. wat Wool alcohols ointment, RP. waY Wool fat, B.P.C. waz Wool fat, hydrous, B.P. wba Wool fat ointment, hydrous, B.N.F. xfg Xylometazoline hydrochloride nasal preparations .. xfh Xylometazoline hydrochloride with antazoline sulphate sterile eye drops and nasal preparations zaa Zinc chloride zad Zinc oxide zag Zinc oxide, colloidal zaj Zinc and castor oil ointment, B.N.F. zam Zinc and coal tar paste, B.N.F. zap Zinc and ichthammol cream, B.P.C. zav Zinc and salicylic acid dusting powder, B.P.C. zaz Zinc and salicylic acid paste, B.P. zbd Zinc cream, B.P. zbg Zinc gelatin, B.P.C. zbm Zinc ointment, B.P. zbp Zinc paste, compound, B.P. zbs Zinc, starch, and talc dusting powder, B.P.C. zbv Zinc stearate zbz Zinc stearate dusting powder, B.N.F. zca Zinc sulphate zcd Zinc sulphate eye drops, B.N.F. zcg Zinc sulphate and adrenaline eye drops, B.P.C•.. zcm Zinc sulphate lotion, B.P.C. zcp Zinc sulphate and zinc chloride mouthwash, B.P.C. 192 Drug Tariff 1970 1970/18

SCHEDULE-continued

PART I1-continued Availabiliry-continued

R~~:ce I Pharmaceutical Requirement Availability

zco I Zinc sulphide lotion, B.N.F. zcs Zinc undecenoate •. zcv Zinc undecenoate dusting powder, B.N.F. zcz Zinc undecenoate ointment, B.N.F. zda Zinc undecenoate and undecenoic acid dusting powder

PART III Manzifacturers Abbott Laboratories, U.S.A. Abbott Laboratories Ltd., England. Abbott Laboratories (N.Z.) Ltd., . Abbott Laboratories Pty. Ltd., . Alcon Universal Ltd., Canada. Alcon Universal Ltd., U.S.A. AlIen and Hanburys Ltd., England. Allergan Pharmaceuticals, Canada. Allergan Pharmaceuticals, U .S.A. Ames Company, Australia. Ankerfarm S.p.A., Italy. Armour Pharmaceutical Company, England. A/B Astra, Sweden. Astra Pharmaceuticals (Aust.) Pty. Ltd., Australia. Ayerst Laboratories Inc., U.S.A. Ayerst Laboratories Pty. Ltd., Australia. A. C. Barnes and Co. Ltd., U.S.A. Bayer Pharma Pty. Ltd., New Zealand. BDH Australia Pty. Ltd., Australia. BDH Chemicals Ltd., England. BDH (Ireland) Ltd., Eire. BDH Pharmaceuticals Ltd., England. BDH South Africa (Pty.) Ltd., South Africa. Booker-BDH Ltd., Guyana. Booker-BDH Ltd., . Booker-BDH Ltd., Trinidad. The British Drug Houses Ltd., England. The British Drug Houses (Aust.) Pty. Ltd., Australia. The British Drug Houses (Canada) Ltd., Canada. Beecham Research Laboratories, England. Behringwerke A.G., West Germany. Berk Pharmaceuticals Ltd., England. Biological Laboratories Ltd., New Zealand. 1970/18 Drug Tariff 1970 193

SCHEDULE-continued

PART Ill-continued

Manzifacturers-continued

Boehringer Ingelheim Pty. Ltd., Australia. Boehringer Mannheim G.m.b.H., West Germany. C. H. Boehringer Sohn, West Germany. Boots Pure Drug Co. Ltd., England. Bristol Laboratories Pty. Ltd., Australia. British Schering Ltd., England. Brocades-Stheeman and Pharmacia, Holland. Burroughs Wellcome and Co., Canada. Burroughs Wellcome and Co., England. Burroughs Wellcome and Co. (Aust.) Ltd., Australia. Burroughs Wellcome and Co. () Private Ltd., India. Burroughs Wellcome and Co. (N.Z.) Ltd., New Zealand. Burroughs Wellcome and Co. (Pakistan) Ltd., West Pakistan. Burroughs Wellcome and Co. (Singapore) Ltd., Singapore. Burroughs Wellcome and Co. (U.S.A.) Inc., U.S.A. Burroughs Wellcome (Pty.) Ltd., South Africa. Deutsche Wellcome G.m.b.H., West Germany. Gayoso Wellcome S.A., Spain. Laboratorios Burroughs Wellcome do Brazil S.A., Brazil. N.V. Wellcome S.A., Belgium. Wellcome Italia S.p.A., Italy. Wellcome Philippines Inc., Philippines. Wellcome Reagents Ltd., England. Calmic Ltd., Canada. Calmic Ltd., England. Calmic (Australia) Pty. Ltd., Australia. Calmic (Pty.) Ltd., South Africa. Camden Chemical Co. Ltd., England. Carlo Erba, Italy. The Central Pharmacal Co., U.S.A. Ciba Basle, Switzerland. Ciba Laboratories Ltd., England. Ciba Pharmaceutical Company, U.S.A. Contract Manufacturers and Packers, Ltd., New Zealand. Cox-Continental Ltd., England. Commonwealth Serum Laboratories, Australia. Crookes Laboratories Ltd., England. Damancy and Co. Ltd., England. Denver Chemical Manufacturing Co., U.S.A. Dista Products (Australia) Pty. Ltd., Australia. Dista Products Ltd., England. Dista Products (N.Z.) and Company, New Zealand. Dolder S.A., Switzerland. AjS Dumex Ltd., Denmark. Duncan, Flockhart, and Evans Ltd., England. Paul B. Elder Co. Inc., U.S.A. Eli Lilly and Company, England. Eli Lilly and Company, U.S.A. Con. Regs.-8 194 Drug Tariff 1970 1970/18

SCHEDULE-continued

PART III-continued Manufacturers-continued Eli Lilly (Australia) and Company, Australia. Eli Lilly (N.Z.) and Company, New Zealand. Endo Laboratories Inc., U.S.A. Ethicals Limited, New Zealand. Ethnor Pty. Ltd., Australia. Evans Medical Ltd., England. Farbenfabriken Bayer A.G., West Germany. Fawns and McAllan Pty. Ltd., Australia. FBA Pharmaceuticals (Aust.) Pty. Ltd., Australia. Ferrosan, Sweden. Fisons Pharmaceuticals Ltd., . Charles E. Frosst and Co., Canada. Fujisawa Pharmaceutical Co. Ltd., Japan. J. R. Geigy S.A., Switzerland. Geigy (U.K.) Ltd., England. Glaxo Benelux S.A., Belgium. Glaxo Benelux S.A., Holland. Glaxo Benelux S.A., Luxembourg. Glaxo Laboratories Ltd., England. Glaxo Laboratories (India) Private Ltd., India. Glaxo Laboratories (Ireland) Ltd., Eire. Glaxo Laboratories (N.Z.) Ltd., New Zealand. Glaxo Laboratories (Pakistan) Ltd., Pakistan. Glaxo Mustahzarlari A.S., Turkey. Glaxo Pharmazeutika G.m.b.H., West Germany. Glaxo-Allenburys (Aust.) Pty. Ltd., Australia. Glaxo-Allenburys (Canada) Ltd., Canada. Glaxo-Allenburys (Ceylon) Ltd., Ceylon. Glaxo-Allenburys (East Mrica) Ltd., . Glaxo-Allenburys (Ghana) Ltd., Ghana. Glaxo-Allenburys () Ltd., Malaysia. Glaxo-Allenburys (Nigeria) Ltd., Nigeria. Glaxo-Allenburys (S.A.) Pty. Ltd., South Mrica. Glaxo-Evans S.A., Switzerland. Glaxo-Vidhyasom Ltd., Thailand. Laboratories Glaxo-Evans, France. Laboratori Glaxo S.p.A., Italy. Laboratorios Glaxo (Argentina) S.A., Argentina. Laboratorios Glaxo (Uruguay) S.A., Uruguay. Laboratorios Glaxo de Colombia S.A., Colombia. Laboratorios Glaxo de Cuba S.A., Cuba. Laboratorios Glaxo de Venezuela G.A., Venezuela. Laboratorios Glaxo-Evans do Brasil S.A., Brazil. Glenwood Laboratories Inc., U.S.A. Australian Hoechst Ltd., Australia. Farbwerke Hoechst A.G., West Germany. Horlicks Pharmaceuticals Ltd., England. Imperial Chemical Industries Ltd., England. 1970/18 Drug Tariff 1970 195

SCHEDULE-continued

PART Ill-continued

Manufacturers-continued

Imperial Chemical Industries of Australia and New Zealand Ltd., Australia. Jassen Pharmaceutica, Belgium. A. B. Kabi, Sweden. The Karitane Products Society Ltd., New Zealand. Kempthorne Prosser Ltd., New Zealand. Thomas Kerfoot and Co. Ltd., England. Lafayette Pharmacal Inc., U.S.A. Lederle Laboratories, U .S.A. Leo Pharmaceutical Products Trading Ltd., Denmark. Leo Laboratories Ltd., Ireland. Lepetit Pharmaceuticals, England. Linson Ltd., Eire. Lloyd's Pharmaceutical Ltd., England. Luitpold Werk Chemisch Pharazeutische Fabrick, West Germany. McGaw Laboratories Inc., U.S.A. Madland Laboratories, Inc., U.S.A. Mallinckrodt Pharmaceuticals, U.S.A. Paul Maney Laboratories Canada Ltd., Canada. Maws Pharmacy Supplies Ltd., England. May and Baker Ltd., England. May and Baker (N.Z.) Ltd., New Zealand. Mead Johnson Pty. Ltd., Australia. Meiji Seika, Japan. E. Merck, West Germany. Merck Sharp and Dohme, U .S.A. Merck Sharp and Dohme (Australia) Pty. Ltd., Australia. Merck Sharp and Dohme of Canada Ltd., Canada. Merck Sharp and Dohme Ltd., England. Merck Sharp and Dohme International, Bermuda. Merck Sharp and Dohme (N.Z.) Ltd., New Zealand. William S. Merrell Company, Australia. Merrell National Overseas Laboratories, England. Merrell National Overseas Laboratories, U.S.A. Miles Laboratories Ltd., England. Moore Medicinal Products Ltd., England. Mycofarm, Holland. Laboratoire Nativelles, France. Nicholas Pty. Ltd., Australia. Nipa Laboratories Ltd., Wales. Norgine Ltd., England. Novo Industri A/S, Denmark. Nysco Laboratories, Inc., U .S.A. Oppenheimer and Son Co. Ltd., England. Orbit Chemicals, Australia. N. V. Organon, Holland. Organon (Australasia) Pty. Ltd., Australia. Organon Laboratories Ltd., England. 8* 196 Drug Tariff 1970 1970/18

SCHEDULE-continued

PART Ill-continued

Manufacturers-continued

Ortho Pharmaceutical Company, Australia. Paines and Byrne Ltd., England. Parke, Davis and Co., Australia. Parke, Davis and Co., England. Parke, Davis and Co., U.S.A. Pfizer Laboratories, Australia. Pfizer Laboratories, U.S.A. Pfizer Ltd., England. J. Pfrimmer and Co., West Germany. Pharmaceutical Manufacturing Co., England. Pharmacia International, Sweden. N. V. Philips-Duphar, Holland. Pierrel S.p.A., Italy. Protea Pharmaceuticals Pty. Ltd., Australia. Recherche et Industrie Therapeutiques S.A., Belgium. Reckitt and Colman (N.Z.) Ltd., New Zealand. Riker Laboratories, England. Riker Laboratories, U .S.A. Riker Laboratories Australia Pty. Ltd., Australia. A. H. Robins Inc., U.S.A. Roche Products Ltd., England. Roche Laboratories, U.S.A. F. Hoffmann La Roche, France. F. Hoffmann - La Roche A.G., Switzerland. Roehm and Haas Pharma G.m.b.H., West Germany. Rona Laboratories Ltd., England. Aktieselskabet Rosco, Denmark. Rotary Tableting Corporation, Australia. Roussel Laboratories Ltd., England. Roussel Pharmaceuticals (Pty.) Ltd., Australia. Salmond and Spraggon Ltd., New Zealand. Sandoz Australia Pty. Ltd., Australia. Sandoz Ltd., Switzerland. Scanpharm A/S, Denmark. R. P. Scherer Ltd., England. Schering A. G., West Germany. Schering Corporation, U.S.A. G. D. Searle and Co. Ltd., England. Selpharm Laboratories Ltd., England. Sharland and Co. Ltd., New Zealand. Sigma Company Ltd., Australia. Smith, Kline, and French Laboratories, U.S.A. Smith, Kline, and French Laboratories (Australia) Ltd., Australia. Smith, Kline, and French Laboratories Ltd., England. Smith, Kline, and French Laboratories (N.Z.) Ltd., New Zealand. Smith, Miller, and Patch (Canada) Ltd., Canada. Smith, Miller, and Patch Inc., U.S.A. Smith and Nephew Pharmaceuticals Ltd., England. 1970/18 Drug Tariff 1970 197

SCHEDULE-continued

PART III-continued

Manufacturers-continued

Societe Monegasque de Chimie Appliquee, Monaco. E. R. Squibb and Sons Inc., U.S.A. E. R. Squibb and Sons Ltd., Canada. E. R. Squibb and Sons Ltd., England. E. R. Squibb and Sons Pty. Ltd., Australia. Sterling Drug Inc., U.S.A. Sterling Pharmaceuticals (N.Z.) Ltd., New Zealand. Sterling Pharmaceuticals Pty. Ltd., Australia. SterlingjWinthrop Group Ltd., England. Stevens Chemicals Ltd., New Zealand. Stevens Industries Ltd., New Zealand. Syntex Pharmaceuticals Ltd., England. Takeda Pharmaceutical Co., Japan. Tanebe Seiyaku Co. Ltd., Japan. Tasman Vaccine Laboratory Ltd., New Zealand. Therapharm Ltd., England. The Upjohn Company, U.S.A. Upjohn Ltd., England. Upjohn Pty. Ltd., Australia. USV Pharmaceutical Corporation, O.S.A. Vasogen Laboratories Ltd., England. Vitamins Ltd., England. Wallace Pharmaceuticals, U.S.A. A. Wander Ltd., England. A. Wander Ltd., Switzerland. Ward Blenkinsop and Co. Ltd., United Kingdom. William R. Warner and Co. Ltd., England. William R. Warner and Co. Ltd., New Zealand. Warner-Lambert International, U.S.A. Warner-Lambert Pty. Ltd., Australia. Westminster Laboratories Ltd., England. West-Silten Pharmaceuticals Ltd., England. Wilsons Malt Co. Ltd., New Zealand. Winthrop Laboratories, Canada. Winthrop Laboratories, O.S.A. Keith Woollams Ltd., New Zealand. Wyeth Laboratories Inc., U.S.A. Wyeth Pharmaceuticals Pty. Ltd., Australia. John Wyeth and Brother Ltd., England. John Wyeth and Brother (N.Z.) Ltd., New Zealand. Wyeth-Pharma, West Germany. Zambon S.p.A., Italy.

Dated at Wellington this 23rd day of February 1970.

D. N. McKAY, Minister of Health. 198 Drug Tariff 1970 1970/18

EXPLANATORY NOTE This note is not part of the Drug Tariff, hut is intended to indicate its general effect. This Drug Tariff sets out the drugs, medicines, and materials that may be supplied at the cost of the Department of Health by chemists and others who have contracted to supply them under the Social Security (Pharmaceutical Benefits) Regulations 1965. It also sets out the terms and conditions of supply, the procedure for the lodging and payment of claims by contractors, and the rules for fixing the prices payable to contractors. The Schedule to the Tariff specifies the materials and classes of materials that are allowed or conditionally allowed at the cost of the Department of Health. Some trade names of the drugs that were not included in any previous Drug Tariff are- Trade Name Official Name Alupent syrup Orciprenaline sulphate. Butazolidin suppositories Phenylbutazone. Hemineurin (Hospital Board-specialist) Chlormethiazole and its esters. Kenacomb (part charge) .. .. Triamcinolone acetonide with nystatin, neo­ mycin sulphate and gramicidin. Mixogen injection .. Oestradiol benzoate with oestradiol phenyl­ propionate, testosterone propionate, testo­ sterone phenylpropionate and injection. Pimafucort (part charge) Hydrocortisone with natamycin and neomycin. Propaderm Forte (Dermatological Beclomethasone dipropionate. specialist-part charge) Pyopen (Hospital Board-specialist) .. Carbenicillin. Regreton Chlorthalidone with reserpine. Salazopyrin suppositories Sulphasalazine. Ventolin aerosol inhaler Salbutamol. Vibramycin (Hospital Board-specialist) Doxycycline hydrochloride.

Issued under the authority of the Regulations Act 1936. Date of notification in Gazette: 5 March 1970. This direction is administered in the Department of Health.